DISCLOSURE 990 Department of the Treasury Internal Revenue Service A For the 2014 calendar year, or tax year beginning and ending Return of Organization Exempt From Income Tax Under section 501(c), 527, or 4947(a)(1) of the Internal Revenue Code (except private foundations) Do not enter social security numbers on this form as it may be made public. Information about Form 990 and its instructions is at its gov/foerQO OMB No. 1545-0047 Eipen to Jublic Inspection Check ir Name of organization Employer identification number ?mime: PHARMACEUTICAL RESEARCH MANUFACTURERS sass OF AMERICA 5:211:13 Doing business as PHRMA Number and street (or P.0. box it mall is not delivered to street address) Room/suite Telephone number $939,, 950 STREET 300 202?835?3400 ?53m- City or town, state or province, country, and ZIP or foreign postal code Gross roan-111w feTuemded WASHINGTON DC 2 0 0 0 4 H(a) Is this a group return ?gr??li?a- Name and address of principal officer: STEPHEN . UBL for subordinates? No pending SAME AS ABOVE H(b) Are all subordinates included? Yes No I Tax-exempt status: 501(c)(3) (XI Sims) 5 )4 (insert no.) or 52? If attach a list. (see instructions) Website: - PHRMA - ORG Hie) Group exemption number Trust Association Other Form oi organization: Part l Summary IL Year oI formation: 1 9 5 3 State at local domicllotDE 1 Briefly describe the organization's mission or most significant activities: SEE SCHEDULE 0 8 2 Check this box if the organization discontinued its operations or disposed of more than 25% of its net assets. 3 Number of voting members of the governing body (Part VI, line is) 3 3 2 4 Number of independent voting members of the governing body (Part VI, line 1b) 4 3 1 a 5 Total number of individuals employed in calendar year 2014 (Part V, line 2a) 5 2 2 7 6 Total number of volunteers (estimate if necessaryTotal unrelated business revenue from Part column (C), line 12 Ta 0 . I: Met unrelated business taxath income from Form QED-T, line 34 7b 0 . Prior Year Current Year 0 8 Contributions and grants (Part line 1h) 0 . 0 . 9 Program service revenue line 2gInvestment income (Part column (A), lines Other revenue (Part column (A), lines 5, 6d, 8C, BC, 10c, and 11e) 20_Total revenue-add lines 8throuqh 11 (must equal Part column (A). line 12Grants and similar amounts paid (Part IX, column (A), lines 1-Benefits paid to or for members (Part IX, column (A), line 4) 0 . 0 . 15 Salaries, other compensation, employee benefits (Part IX, column (A), lines 5-1016a Professional fundraising fees (Part IX, column (A), line He) 0 . 0 . E. Total fundraising expenses (Part IX, column (D), line 25) 0 . 17 OtherexpenSes(Parth, column (A), lines11a-11d, 11f?24e) 132,706,908. 137,771,125. 18 Total expenses. Add lines 13-17 (must equal Part IX, column (A), line 25Revenue less expenses. Subtract line 18 from line Mnning of Current Year End of Year EC 20 Totalassets(PartX,Iine16) 130,150,555. 135,545,781. 4 airmammw%uenxnm2d 46,428,561. 93,194,442. 22 Net assets orfund balances. Subtractline 21 from line20 83,731, 994. 42, 351 339 . Patti) Signature Block Under penalties of perjury, I declare the true, correct, and complewp?mati?memr (sun?sh gtjicerl is based on all information of which preparer has any knowledge. ave examined this return, including accompanying schedules and statements, and to the best of my knowledge and belief, it is 2 Sign Signature oi oliicer Date Here STEPHEN . UBL PRESIDENT CEO Type or print name and title Print/Type preparer's name Wis arer's signatu Date gm" Pill? Paid DEBORAH . KOSNETT :i I 11/ 1/ 1 5 self-emnloved Preparer Firm's name i TATE AND TRYON Firrn's Ellil Use Only Firm's address 2 0 21 STREET NW SUITE 4 0 0 WASHINGTON, DC 20036 Phonerru,(202} 293-2200 May the IRS discuss this return with the preparer shown above? (see instructions) Yes No 432001 11?07?14 LHA For Paperwork Reduction Act Notice, see the separate instructions. Form 990 (2014) PHARMACEUTICAL RESEARCH MANUFACTURERS Form 990 (2014} OF AMERICA Page 2 Part [Statement of Program Service Accomplishments Checkif ScheduleO contains aresponse or note to anv line in this .. .. .. .. . . .. . . . 1 Briefly describe the organization's mission: MISSION IS WINNING ADVOCACY FOR PUBLIC POLICIES THAT ENCOURAGE THE DISCOVERY OF LIFE-SAVING AND NEW MEDICINES FOR PATIENTS BY RESEARCH COMPANIESDid the organization undertake any .t ac. Vluuo .g t. .e ycal w: not the prior Form 990 or Yes No it "Yes," describe these new services on Schedule 0. 3 Did the organization cease conducting, or make significant changes in how it conducts. any program services? Yes No If "Yes," describe these changes on Schedule 0. 4 Describe the organization?s program service accomplishments for each of its three largest program services, as measured by expenses. Section 501(c)(3) and 501(c)(4) organizations are required to report the amount of grants and allocations to others, the total expenses, and revenue. if any, for each program service reported. 43 (Code: (Expenses including grants of (Revenue PUBLIC POLICY ADVOCACY: MISSION IS TO CONDUCT EFFECTIVE ADVOCACY FOR PUBLIC POLICIES THAT ENCOURAGE DISCOVERY OF IMPORTANT NEW MEDICINES FOR PATIENTS BY RESEARCH COMPANIES. PHRMA ACHIEVES THIS MISSION BY WORKING WITH, AND ON BEHALF OF, ITS MEMBER COMPANIES BEFORE GOVERNMENTAL AND REGULATORY BODIES IN THE UNITED STATES AND THROUGHOUT THE WORLD IN SUPPORT OF PRO-PATIENT, POLICIES. SPECIFICALLY. PHRMA ADVOCATES FOR BROAD PATIENT ACCESS TO SAFE AND EFFECTIVE MEDICINES THROUGH A FREE MARKET, WITHOUT GOVERNMENT PRICE STRONG INTELLECTUAL PROPERTY AND TRANSPARENT, EFFICIENT REGULATION AND A FREE FLOW OF INFORMATION TO PATIENTS. (Code: (Expenses including grants 01? (Revenue MEMBER SERVICES: IN REPRESENTING THE LEADING PHARMACEUTICAL RESEARCH AND BIOTECHNOLOGY COMPANIES, PHRMA PROVIDES A FORUM FOR MEMBER COMPANIES TO PARTICIPATE IN DISCUSSIONS OF RELEVANT HEALTH CARE ISSUES AND TO DEVELOP CONSENSUS POSITIONS ON MATTERS OF PUBLIC POLICY ADVOCACY. MEMBER COMPANIES PARTICIPATE IN PHRMA ACTIVITIES THROUGH REPRESENTATION ON THE BOARD OF DIRECTORS, COMMITTEES AND KEY ISSUE TEAMS, STAFF WORK GROUPS, SECTIONS, TASK FORCES, AND SUBCOMMITTEES. MEMBER COMPANY REPRESENTATIVES ALSO REGULARLY COMMUNICATE WITH PHRMA STAFF. 4C (Code: (Expenses including grants of (Revenue GENERAL EDUCATION ABOUT BIOPHARMACEUTICAL INDUSTRY: PHRMA DISSEMINATES INFORMATION ABOUT BIOPHARMACEUTICAL COMPANIES, THEIR PRODUCTS, AND THEIR BUSINESS, SCIENTIFIC AND PHILANTHROPIC ACTIVITIES THROUGH A WIDE RANGE OF CHANNELS, INCLUDING PROFILES, REPORTS, PRINCIPLES, GUIDELINES, FACT SHEETS, POLICY PAPERS AND OTHER RESOURCES. THESE EFFORTS BOLSTER ABILITY TO EDUCATE AND INFORM MEMBERS OF THE GENERAL PUBLIC AS WELL AS POLICYMAKERS, THE MEDIA, PATIENTS AND OTHERS IN THE HEALTH CARE COMMUNITY ABOUT THE BIOPHARMACEUTICAL INDUSTRY AND PUBLIC POLICY ACTIVITIES IN PARTICULAR. 4d Other program services (Describe in Schedule 0.) (Expenses 3 including grants of (Revenue 4e Total program service expenses Form 990 (2014) 432002 11?07-14 2 12161109 790809 53?0241211 2014.05000 PHARMACEUTICAL RESEARCH 53?02411 PHARMACEUTICAL RESEARCH S: MANUFACTURERS Form sealants) OF AMERICA 53?0241211 Paqe3 Part IV Checklist of Required Schedules Yes No 1 Is the organization described in section 501(c)(3) or 4947(a)(1) (other than a private foundation)? If "Yes," complete Schedule A 1 2 IS the organization required to complete Schedule B, Schedule of Contributors? 2 3 Did the organization engage in direct or indirect political campaign activities on behalf of or in opposition to candidates for public office? If "Yes," complete Schedule C, Part 3 4 Section 501(c)(3) organizations. Did the organization engage in lobbying activities, or have a section 501 election in effect during the tax year? If "Yes," complete Schedule 0, Part ll 4 A 5 Is the organization a section 501(c)(4), 501(c)(5), or 501(c)(6) organization that receives membership dues, assessments, or similar amounts as defined in Revenue Procedure 98-19? If "Yes, complete Schedule C, Pan 5 6 Did the organization maintain any donor advised funds or any similar funds or accounts for which donors have the right to provide advice on the distribution or investment of amounts in such funds or accounts? If "Yes, complete schedule D, Part] 6 7 Did the organization receive or hold a conservation easement, including easements to preserve open space, the environment, historic land areas, or historic structures? If "yes, complete schedule D, Part ll 7 8 Did the organization maintain collections of works of art, historical treasures, or other similar assets? If "Yes, complete Schedule D, Part 8 9 Did the organization report an amount in Part X, line 21, for escrow or custodial account liability; serve as a custodian for amounts not listed in Part or provide credit counseling, debt management, credit repair, or debt negotiation services? If "Yes," complete Schedule D, Part IV 9 10 Did the organization, directly or through a related organization, hold assets in temporarin restricted endowments, permanent endowments, or quasi-endowmemS? If "Yes," complete Schedule D, Part 10 11 If the organization's answer to any of the following questions is "Yes," then complete Schedule D, Parts VI, VII, IX, or as applicable. a Did the organization report an amount for land, buildings, and equipment in Part X, line 10? If "yes, complete schedule Dr Part Vl 113 Did the organization report an amount for investments - other securities in Part X, line 12 that is 5% or more of its total assets reported in Part X. line 16? If "Yes," complete Schedule D, Part 11b Did the organization report an amount for investments - program related in Part X, line 13 that is 5% or more of its total assets reported In Part X. ?'16 15? If "Yes, complete Schedule D, Part 11C Did the organization report an amount for other assets in Part X, line 15 that is 5% or more of its total assets reported in Part X, line 16? If "Yes, complete Schedule D, Part IX 11d Did the organization report an amount for other liabilities in Part X, line 25? If "Yes, complete Schedule D, Partx 11e Did the organization's separate or consolidated financial statements for the tax year include a footnote that addresses the organization's liability for uncertain tax positions under FIN 48 (A80 740)? ff "Yes, complete schedule D, Part 11f 12a Did the organization obtain separate, independent audited financial statements for the tax year? If "Yes, complete Schedule D, Parts XI and 12a Was the organization included in consolidated, independent audited financial statements for the tax year? If "Yes," and if the organization answered "No" to line 123, then completing Schedule D, Parts Xl and is optional 12b 13 Is the organization a school described in section If "yes, complete Schedule 13 143 Did the organization maintain an office, employees, or agents outside of the United States? 143 Did the organization have aggregate revenues or expenses of more than $10,000 from grantmaking, fundraising, business, investment, and program service activities outside the United States, or aggregate foreign investments valued at $100,000 or more? If "Yes," complete Schedule F, Parts land lI/ 14b 15 Did the organization report on Part IX, column (A), line 3, more than $5,000 of grants or other assistance to or for any foreign organization? lf "Yes, complete Schedule F, Parts ll and IV 15 16 Did the organization report on Part IX, column (A), line 3, more than $5,000 of aggregate grants or other assistance to or for foreign individuals? If "Yes," complete Schedule F, Parts and IV 16 17 Did the organization report a total of more than $15,000 of expenses for professional fundraising services on Part IX, column (A). lines 6 and 116? If "Yes," complete Schedule G, Partl 17 18 Did the organization report more than $15,000 total of fundraising event gross income and contributions on Part lines 10 and 88? if "Yes," complete Schedule G, Part ll 18 19 Did the organization report more than $15,000 of gross income from gaming activities on Part line 9a? If "Yes, complete Schedule G, Part 19 20a Did the organization operate one or more hospital facilities? it "Yes, complete schedule 203 If 'Yes? to line 203, did the organization attach a copy or its audited financial statements to this return? . .. .. ., 20b Form 990 (2014) 432003 11-07-14 3 12161109 790809 53?0241211 2014.05000 PHARMACEUTICAL RESEARCH 8: 53?02411 PHARMACEUTICAL RESEARCH MANUFACTURERS Forn1990 [2014) OF AMERICA 53-0241211 Paqe4 iart IV [Checklist of Required _S_Eh_edules (Continued) Yes No 21 Did the organization report more than $5,000 of grants or other assistance to any domestic organization or domestic government on Part IX, column (A), line 1? If "Yes, Complete schedule parts [and 21 22 Did the organization report more than $5,000 of grants or other assistance to or for domestic individuals on Part IX. column (A). line 2? If "Yes," complete Schedule I, Parts land 22 23 Did the organization answer "Yes" to Part VII, Section A, line 3, 4, or 5 about compensation of the organization's current Ah? r. .. .. and formeroff'cere, directors nu - if ?Yes, complete Schedule 23 24a Did the organization have a tax-exempt bond issue with an outstanding principal amount of more than $100,000 as of the last day of the year, that was issued after December 31, 2002? If "Yes, answer lines 24b through 24d and complete Schedule K. If go to llne 25a 24a Did the organization invest any proceeds of tax-exempt bonds beyond a temporary period exception? 24b Did the organization maintain an escrow account other than a refunding escrow at any time during the year to defease any tax-exempt bonds? 24c Did the organization act as an "on behalf of" issuer for bonds outstanding at any time during the year? 24d 25a Section 501(c)(3), 501(c)(4), and 501(c)(29) organizations. Did the organization engage in an excess benefit transaction with a disqualified person during the year? ,If "Yes, complete schedule L, Pan] 25a Is the organization aware that it engaged in an excess benefit transaction with a disqualified person in a prior year, and that the transaction has not been reported on any of the organization's prior Forms 990 or If "Yes, complete Schedule Partl 25b A 26 Did the organization report any amount on Part X, line 5, 6, or 22 for receivables from or payables to any current or former officers, directors, trustees, key employees, highest compensated employees, or disqualified persons? If "Yes, complete Schedule L, Pelt ll 26 27 Did the organization provide a grant or other assistance to an officer, director, trustee, key employee, substantial contributor or employee thereof, a grant selection committee member, or to a 35% controlled entity or family member of any of these persons? lf Yes, complete Schedule L, Part 27 28 Was the organization a party to a business transaction with one of the following parties (see Schedule L, Part IV instructions for applicable filing thresholds, conditions, and exceptions): a A current or former officer, director, trustee, or key employee? If "Yes, complete Schedule L, part 28a A family member of a current or former officer, director, trustee, or key employee? If "Yes, complete schedule L, Part ,lV 23b .3: An entity of which a current or former officer, director, trustee, or key employee (or a family member thereof) was an officer, director, trustee, or direct or indirect owner? lf "yes, complete Schedule L, Part IV 28c 29 Did the organization receive more than $25,000 in non-cash contributions? If "Yes_ complete schedule 29 30 Did the organization receive contributions of art, historical treasures, or other similar assets, or qualified conservation COHtlibUtionS? If "Yes," complete Schedule 30 31 Did the organization liquidate, terminate, or dissolve and cease operations? If "Yes," complete Schedule N, Parfl 31 32 Did the organization sell, exchange, dispose of, or transfer more than 25% of its net assets? If "Yes, complete Schedule N, Part ll 32 33 Did the organization own 100% of an entity disregarded as separate from the organization under Regulations sections 301 .7701-2 and 301.7701-3? it "Yes, I- complete Schedule a, Part 33 34 Was the organization related to any tax-exempt or taxable entity? If "Yes, complete schedule H, part ll, ll], or ll/r and Part V, llhe 1 . .. 34 35a Did the organization have a controlled entity within the meaning of section 512(b)(13)? 35a it "Yes" to line 35a, did the organization receive any payment from or engage in any transaction with a controlled entity within the meaning of section 512(b)(13)? If "Yes," complete Schedule a, Part v, llne 2 35b 36 Section 501(c)(3) organizations. Did the organization make any transfers to an exempt non-charitable related organization? lf "Yes," complete Schedule Fl, Part V, line 2 36 A 37 Did the organization conduct more than 5% of its activities through an entity that is not a related organization and that is treated as a partnership for federal income tax purposes? If "Yes, complete Schedule H, part 37 38 Did the organization complete Schedule 0 and provide explanations in Schedule 0 for Part VI, lines 11b and 19? Note. NJfor-m 990 filers are required to complete Schedule 0 .l 38 Form 990 (2014) 432004 11-07-14 4 12161109 790809 53?0241211 2014.05000 PHARMACEUTICAL RESEARCH 53?02411 PHARMACEUTICAL RESEARCH 8c MANUFACTURERS Form 990 [2014] OF AMERICA Page 5 Part Statements Regarding Other and Tax Compliance Check if Schedule 0 contains a response or note to any line in this Part Enter the number reported in Box 3 of Form 1096. Enter -0- if not applicable fa 4 3 6 Enter the number of Forms W-2G included in line 1a. Enter -0- if not applicable 1b 0 Did the organization comply with backup withholding rules for reportable payments to vendors and reportable gaming (gambling) winnings to prize winners? . 1c 2a Enter the number of employees reported on Form W-3, Transmittal of Wage and Tax Statements, filed for the calendar year ending with or within the year covered by this return 23 2 2 7 If at least one is reported on line 2a, did the organization file all required federal employment tax returns? 2b Note. If the sum of lines 1a and 2a is greater than 250, you may be required to e-?le (see instructions) 3a Did the organization have unrelated business gross income of $1 ,000 or more during the year? 3a If "Yes, has it filed a Form 990-T for this year? If "No, to line 3b, provide an explanation in Schedule 0 3b 4a At any time during the calendar year, did the organization have an interest in, or a signature or other authority over, a financial account in a foreign country (such as a bank account. securities account, or other financial account)? 43 If "Yes," enter the name of the foreign country: JAPAN UNITED ARAB EMIRATES See instructions for filing requirements for Form 114, Report of Foreign Bank and Financial Accounts (FBAR). 53 Was the organization a party to a prohibited tax shelter transaction at any time during the tax year? 5a Did any taxable party notify the organization that it was or is a party to a prohibited tax shelter transaction? 5b If "Yes," to line 5a or 5b, did the organization file Form 5c 6a Does the organization have annual gross receipts that are normally greater than $100,000, and did the organization solicit any contributions that were not tax deductible as charitable contributions? If "Yes," did the organization include with every solicitation an express statement that such contributions or gifts were not tax deductible? 6b 7 Organizations that may receive deductible contributions under section 170(c). A a Did the organization receive a payment in excess of $75 made partly as a contribution and partly for goods and services provided to the payer? Ta If "Yes," did the organization notify the donor of the value of the goods or services provided? 7b Did the organization sell, exchange, or otherwise dispose of tangible personal property for which it was required to file Form 8282? 7c If "Yes," indicate the number of Forms 8282 filed during the year I 7d Did the organization receive any funds, directly or indirectly, to pay premiums on a personal benefit contract? 7e Did the organization, during the year, pay premiums, directly or indirectly, on a personal benefit contract? 7f 9 If the organization received a contribution of qualified intellectual property, did the organization file Form 8899 as required? 79 A If the organization received a contribution of cars, boats, airplanes, or other vehicles, did the organization file a Form 1098-0? 7h A. 8 Sponsoring organizations maintaining donor advised funds. Did a donor advised fund maintained by the sponsoring organization have exoess business holdings at any time during the year? 8 9 Sponsoring organizations maintaining donor advised funds. a Did the sponsoring organization make any taxable distributions under section 4966? 9a Did the sponsoring organization make a distribution to a donor, donor advisor, or related person? 9b 10 Section 501(c)(7) organizations. Enter: a Initiation fees and capital contributions included on Part line 12 103 Gross receipts, included on Form 990, Part line 12, for public use of club facilities 10b 11 Section 501(c)(12) organizations. Enter: a Gross income from members or shareholders 11a Gross income from other sources (Do not net amounts due or paid to other sources against amounts due or received from them.) 11b 12a Section 4947(a)(1) non-exempt charitable trusts. Is the organization filing Form 990 in lieu of Form 1041 12a If "Yes," enter the amount of tax-exempt interest received or accrued during the year A. 12b 13 Section 501(c)(29) qualified nonprofit health insurance issuers. a is the organization licensed to issue qualified health plans in more than one state? 133 Note. See the instructions for additional information the organization must report on Schedule 0. Enter the amount of reserves the organization is required to maintain by the states in which the organization is licensed to issue qualified health plans Enter the amount of reserVes on hand 13c 14a Did the organization receive any payments for indoor tanning services during the tax year? 143 If "Yes," has it filed a Form 720 to report these payments? we," an 330W 0 1413 Form 990 (2014) 432005 11?07?14 5 12161109 790809 53~0241211 2014.05000 PHARMACEUTICAL RESEARCH 53?02411 PHARMACEUTICAL RESEARCH MANUFACTURERS Form see {2014) OF AMERICA 53?0241211 pages Part VI Governance: Management: and DISGIOSUW For each "Yes" response to lines 2 through 7b below, and fora "No" response to line 8a, 8b, or 10b below, describe the circumstances, processes, or changes in Schedule 0. See instructions. Check if Schedule 0 contains a response or note to any line in this Part Section A. Governing Body and Manag??nent Yes No ta Enter the number of voting members of the governing body at the end of the tax year 1a 3 2 If there are material differences in voting rights among members of the governing body, or if the governing body delegated broad authority to an executive committee or similar committee, explain in Schedute O. Enter the number of voting members included in ine 1a, above, who are independent 1b 31 2 Did any officer, director, trustee, or key employee haVe a family relationship or a business relationship with any other officer, director, trustee, or key employee? 2 3 Did the organization delegate control over management duties customarily performed by or under the direct supervision of officers, directors, or trustees, or key employees to a management company or other person? 3 4 Did the organization make any significant changes to its governing documents since the prior Form 990 was ?led? 4 5 Did the organization become aware during the year of a significant diversion of the organization's assets? 5 6 Did the organization have members or stockholders? 6 73 Did the organization have members, stockholders, or other persons who had the pOWer to elect or appoint one or more members of the governing body? 7a Are any governance decisions of the organization reserved to (or subject to approval by) members, stockholders, or persons other than the governing body? 7b 8 Did the organization contemporaneously document the meetings held or written actions undertaken during the year by the following: a The governing body? 8a Each committee with authority to act on behalf of the governing body? 8b 9 Is there any officer, director, trustee, or key employee listed in Part Vll, Section A, who cannot be reached at the organization's mailing addressSeCtiO" 3- P?li?ies Finis Section muesli: ?n?DrmaW?Q?m??mut?bLm?J?l?mai Revenue Code] Yes No 10a Did the organization have local chapters, branches, or affiliates? 103 If "Yes," did the organization have written policies and procedures governing the activities of such chapters, affiliates, and branches to ensure their operations are consistent with the organization's exempt purposes? 10b 11a Has the organization provided a complete copy of this Form 990 to all members of its governing body before filing the form? 11a Describe in Schedule 0 the process, if any, used by the organization to review this Form 990. 123 Did the organization have a written conflict of interest policy? ,If "No, go to line 13 123 Were officers, directors, or trustees, and key employees required to disclose annually interests that could give rise to conflicts? 12b Did the organization regularly and consistently monitor and enforce compliance with the policy? if "Yes, describe in Schedule 0 how this was done 12c 13 Did the organization have a written whistleblower policy? 13 14 Did the organization have a written document retention and destruction policy? 14 15 Did the proccss for determining compensation of the following persons include a review and approval by independent persons, comparability data, and contemporaneous substantiation of the deliberation and decision? a The organization's CEO, Executive Director, or top management official 15a Other officers or key employees of the organization 1513 If "Yes" to line 15a or 15b, describe the process in Schedule 0 (see instructions). 16a Did the organization invest in, contribute assets to, or participate in a joint venture or similar arrangement with a taxable entity during the year? . 163 If "Yes," did the organization follow a written policy or procedure requiring the organization to evaluate its participation in joint venture arrangements under applicable federal tax law, and take steps to safeguard the organization's exempt status with reopect to such shaman-rents? 15:; Section 0. Disclosure 17 List the states with which a copy of this Form 990 is required to be filed FCA 18 Section 6104 requires an organization to make its Forms 1023 (or 1024 if applicable), 990, and 990-T (Section 501 only) available for public inspection. indicate how you made these available. Check all that apply. Own website I: Another's website Upon request :1 Other (explain in schedule 0) 19 Describe in Schedule 0 whether (and if so, how) the organization made its governing documents, conflict of interest policy, and financial statements available to the public during the tax year. 20 State the name, address, and telephone number of the person who possesses the organization's books and records: PAUL A. AINES (INCOMING CFO) 202?835?3400 950 STREET NO. 300 WASHINGTON, DC 20004 432006 11-07-14 Form 990 (2014) 12161109 790809 53-0241211 6 2014.05000 PHARMACEUTICAL RESEARCH 8: 53?02411 PHARMACEUTICAL RESEARCH Sc MANUFACTURERS Form 990 {2014} 53?0241211 Paqe7 Part V l Compensation of Officers, Directors, Trustees, Key Employees, Highest Compensated Employees, and Independent Contractors Check if Schedule 0 contains a response or note to any line in this Part VII El Section A. Officers, Directors. Trustees, Key Employees, and Hiqhest Compensated Employees 1a Complete this table for all persons required to be listed. Report compensation for the calendar year ending with or within the organization's tax year. 0 List all of the organization?s current officers. directors. trustees (whether individuals or organizations), regardless of amount of compensation. Enter -0- in columns (D), (E), and (F) if no compensation was paid. 0 List all of the organization?s current key employees. if any. See instructions for definition of "key employee." 0 List the organization's five current highest compensated employees (other than an officer, director, trustee, or key employee) who received report- able compensation (Box 5 of Form W-2 and/or Box 7 of Form 1099-MISC) of more than $100,000 from the organization and any related organizations. 0 List all of the organization?s former OffiCers, key employees, and highest compensated employees who received more than $100,000 of reportable compensation from the organization and any related organizations. 0 List all of the organization?s former directors or trustees that received, in the capacity as a former director or trustee Of the organization, more than $10,000 of reportable compensation from the organization and any related organizations. List persons in the following order: individual trustees or directors; institutional trustees: officers; key employees; highest compensated employees; and former such persons. I I Check this box if neither the organization nor any related organization compensated any current officer. director, or trUstee (A) (B) (D) (E) (F) Name and Title Average (do notc?g?'??than one Reportable Reportable Estimated hours per box, unless person is both an compensation compensation amount of week officer anda director/trustee) from from related other (list any the organizations compensation hours for 1: organization from the related 2 organization organizations and related below as, organizations line) 2% IAN READ 2 . 0 CHAIRMAN KENNETH C. FRAZIER GEORGE A. SCANGOS, PHD 2 . 00 TREASURER MARK ALTMEYER 2 . 0 0 DIRECTOR TOM AMICK 2 . 0 0 DIRECTOR LAMBERTO ANDREOTTI 2 . 0 0 DIRECTOR . 0 0 . 0 . . MICHAEL BONNEY 2 . 0 DIRECTOR ROBERT A. BRADWAY 2 . 0 0 DIRECTOR OLIVIER BRANDICOURT, MD 2 . 0 0 DIRECTOR DOUG COLE 2 . 0 0 DIRECTOR DEIRDRE P. CONNELLY 2 . 0 0 DIRECTOR JOAQUIN DUATO 2 . 0 0 DIRECTOR PAUL R. FONTEYNE 2 . 0 0 DIRECTOR BELEN GARIJO 2 . 0 0 DIRECTOR RICHARD GONZALEZ 2 . 0 0 DIRECTOR GLENN J. GORMLEY, MD, PHD 2 . 00 DIRECTOR ROBERT HUGIN 2 . 0 0 DIRECTOR 432007 11-07?14 Form 990 (2014) 7 12161109 790809 53?0241211 2014.05000 PHARMACEUTICAL RESEARCH 53?02411 PHARMACEUTICAL RESEARCH S: MANUFACTURERS ann OF AMERICA 5 3-0241211 Page 3 Section A. Officers. Directors, Trustees. Key Employees. and Highest Cnmpensaterl Employees {commuted} (A) (B) (C) (D) (E) (F) Name and title (do not c?gf?cr?gthan one Reportable Reportable Estimated hours Per box, unless person is both an compensation compensation amount Of week officer and a director/trustee) from from related other (list any the organizations compensation hours for f; organization from the related organization organization? a and related as) organizations line) JOSEPH JIMENEZ 2 . 0 DIRECTOR JOHN C. LECHLEITER, PHD 2 . 00 DIRECTOR DAVE LEMUS 2 . 00 DIRECTOR YUJI MATSUE 2 . 0 0 DIRECTOR CLIVE A. MEANWELLDIRECTOR MICHAEL A. NARACHI 2 . 0 0 DIRECTOR RICHARD F. POPS 2 . 00 DIRECTOR JAMES ROBINSON 2 . 0 0 DIRECTOR BRENT SAUNDERS 2 . 0 0 DIRECTOR Sub-total 0 - 0 0 - Total from continuation sheets to Part VII, Section 11.157,055- 58.058- 4021775- 2 Total number of individuals (including but not limited to those listed above) who received more than $100,000 of reportable compensation from the Organization 1 4 0 Yes No 3 Did the organization list any former officer, director, or trustee, key employee, or highest compensated employee on line 18? if "Yes, complete Schedule for such individual 3 4 For any individual listed on line 1a, is the sum Of reportable compensation and other compensation from the organization and related organizations greater than $150,000? if "Yes, complete schedule for such individual 4 5 Did any person listed on line 1a receive or accrue compensation from any unrelated organization or individual for services . A I 5 Section B. Independent Contractors 1 Complete this table for your five highest compensated independent contractors that received more than $100,000 of compensation from the organization. Report cornpensation [or the calendaiyeai ending with or within the organization's tax year. (A) (B) (C) Name and business address Description of services Compensation GLOVER PARK GROUP LLC 1025 STREET, NW., 9TH FLOOR WASHINGTON, DC 20004 RELATIONS WORK FOR 2,694,091. COVINGTON BURLING LLP TOTAL, 1201 LEGAL CONSULTING AVE . NW, WASHINGTON, DC 2 0 0 4 SERVICES 2 5 1 0,5 15 . AVALERE HEALTH LLC TOTAL 3 5 0 CONNECTICUT SUPPORT AVE. STE 900, WASHINGTON, DC 20036 WORK FOR POLICY 2,398,552. INTEGRATED LEGISLATIVE STRATEGIES LLC TOTAL 701 8TH STREET, NW., STE 520, WASHINGTON, WORK 1,613,907. PUBLIC AFFAIRS COMPANY TOTAL 3 3 3 SOUTH MED IA SEVENTH STREET, STE . 2250 MINNEAPOLIS MN RELATIONS WORK 1 607,23 3 . 2 Total number of independent contractors (including but not limited to those listed above) who received more than $100,000 Of compensation liom the organization 9 2 SEE PART VII, 432005 11-07-14 SECTION A CONTINUATION SHEETS 12161109 790809 53?0241211 Form 990 (2014) 8 2014.05000 PHARMACEUTICAL RESEARCH 8: 53?02411 PHARMACEUTICAL RESEARCH MANUFACTURERS Form990__ OF AMERICA 53-0241211 [Part Section A. Officers, Directors. Trustees, Key Employees, and Highest Compensated Empon aes (continued: (A) (B) (C) (D) (E) (F) Name and title Average Position Reportable Reportable Estimated hours (check all that apply) compensation compensation amount of per from from related other week a the organizations compensation (list any 3 organization from the hours for ii organization related and related organizations 2 7% i organizations below 5 2 line) LARS REBIEN SORENSEN 2 . 0 0 DIRECTOR . 0 0 0 0 . 0 PASCAL SORIOT 2 . 0 0 DIRECTOR NOBUHIKO TAMURA, MS 2 . 0 0 DIRECTOR DANIEL TASSE 2 . 0 0 DIRECTOR MARK TIMNEY 2 . 0 0 DIRECTOR JOHN J. CASTELLANI 3 7 . 5 0 0.00 2,564,767. 0. 554,075. ARDELL PERSINGER 3 1 . 5 0 CFO, EVP 6.00 508,510. 58,058. 693,238. JAMES SPEARS 3 7 . 5 0 0.00 686,318. 0. 97,906. JEFF BOND 3 7 . 5 0 SENIOR VP 0.00 536,840. 0. 243,047. WILLIAM CHIN 37 . 50 EVP 0.00 1,000,160. 0. 60,037. CHARLES CLAPTON 37 . 5 0 SENIOR VP 0.00 363,331. 0. 43,510. CHESTER DAVIS 37 . 5 0 0.00 794,271. 0. 233,602. ROSZELL HUNTER 37 . 5 0 SENIOR VP 0.00 483,631. 0. 172,262. SCOTT LAGANGA 37 . 5 0 SENIOR VP 0.00 365,119. 0. 191,383. JOSEPHINE MARTIN 37 . 50 EVP 0.00 493,927. 0. 174,830. LORI REILLY 37 . 5 0 EVP 0.00 491,324. 0. 456,411. SALVATORE ALESCI 3 7 . 5 0 VICE PRESIDENT 0.00 396,750. 0. 53,186. JENNIFER BRYANT 37 . 5 0 VICE PRESIDENT 0.00 446,325. 0. 339,802. SANDEEP DRAR 37 . 5 0 VICE PRESIDENT 0.00 679,557. 0. 322,705. JAY TAYLOR 37 . 5 0 VICE PRESIDENT 0.00 447,723. 0. 220,199. L??toPmtvaembnAJME1c 432201 05?01-14 9 12161109 790809 53-0241211 2014.05000 PHARMACEUTICAL RESEARCH 53?02411 PHARMACEUTICAL RESEARCH S: MANUFACTURERS OF AMERICA Trus (Al (B) (C) (D) (E) (F) Name and title Average Position Reportable Reportable Estimated hours (check all that apply) compensation compensation amount of per from from related other week the organizations compensation (list any organization from the hours for organization and reiated organizations 53?0241211 uu individual trustee or director Highest compensated employee Institutional trustee Key employee line) IRA WOLF 37 . 50 JAPAN REPRESENTATIVE 0 . 0 0 898 503. . 165 583. Section line1c 11 157 056. 58 0584 021 776. 432201 05-01?14 10 12161109 790809 53?0241211 2014.05000 PHARMACEUTICAL RESEARCH 8: 53?02411 PHARMACEUTICAL RESEARCH MANUFACTURERS OF AMERICA Form 990 +2114) Part I Statement of Revenue Check it Schedule 0 contains a response or note to aniline in this Part 53?0241211 Page 9 (A) Total revenue . Related or exempt function revenue (Cl Unrelated business revenue {Di Revenue excluded from is; under sections 512 - 514 Contributions. Gifts, Grants Other Federated campaigns 1a Membership dues Fundraising events Related organizations 1d Government grants (contributions) 'te All other contributions, gifts, grants, and similar amounts not included above 1f 1b 1c Noncash contributions included in lines Ia-?lf: Total. Add ?nes ?lar'lf p. MEMBERSHIP DUES Business Code 900099 201,992,168. 201,992,168. MEETINGS SECTIONS STUDIES 900099 3,357,533. 3,367,533. Program Service Revenue .1: - a. e- a: All other program service revenue Total. Add lines 231-2! .. .. 205,359,701. Royalties Gross rents DQOUDJ Gain or (loss) (I Net gain or (loss) including Part lV, line 18 Other Revenue Part IV, line 19 10 a and allowances 0 Less: rental expenses Rental income or (loss) Net rental income or (loss) Gross amount from sales of assets other than inventory Less: cost or other basis and sales expenses 3 Investment income (including dividends, interest, and other similar amounts) 4 Income from investment of tax-exempt bond proceeds p. 1,245,061. 1,246,061. Real {Ii} Personal b- fi) Securities Iii} Other 2,067,725. 0. 55,031. 2,067,725, ?55,031. 8 a Gross income from fundraising events (not of contributions reported on line 1c). See Less: direct expenses Net income or (loss) from fundraising events 9 a Gross income from gaming activities. See Less: direct expenses Net income or (loss) from gaming activities Gross sales of inventory. less returns Less: cost of goods sold Net income or (loss) from sales of inventory h- 2,012,694. 2,012,594. P- Miscellaneous Revenue Busines? Code OTHER INCOME 900099 33,550. 33,650. 00.059) All other revenue Total. Add lines 11a-11d 12 Tul? revenue. See instructions. 33,550, 208,652,106, 205,359,701. 3,292,405. 12161109 790809 53?0241211 11 Form 990 (2014) 2014.05000 PHARMACEUTICAL RESEARCH 53-02411 PHARMACEUTICAL RESEARCH MANUFACTURERS Forrn son [2014) OF AMERICA 5 3 0 2412 11 Page 10 Part Statement of Functional Expenses Check if Schedule 0 containsa response or note to any line in this Part not include amounts re orted on lines 6bParfvm. Tm? memes ?232,122?? yet?etgf$$?n222 1 Grants and other assistance to domestic organizations and domestic governments. See Part IV, line Grants and other assistance to domestic. individuals. See Part IV, line 22 3 Grants and other assistance to foreign organizations, foreign governments, and foreign individuals. See Part IV, lines Benefits paid to or for members 5 Compensation of current officers, directors, trustees, and key employees Compensation not included above, to disquali?ed persons (as defined under section 4958(f)(1)) and persons described in section 4958(o)(3)(B) 7 Other salaries and wages Pension plan accruals and contributions (include section 401(k) and 403(b) employer contributionsOther employee benefits Payrolltaxes 2,031,987. 11 Fees for services (non-employees): a Management Legal 9,677,272. Accounting 226 419 . Lobbying 36,091,725. Professional fundraising services. See Part IV, line 17 Investment management fees Other. (Ifline 11g amountexceeds 10% of line 25, column (A) amount, list line 11g expenses Advertising and promotion Office expenses 1 542 445 . 14 Information technology Royalties 16 Occupancy 5,742,159. 17 Travel 4,154,511. 18 Payments of travel or entertainment expenses for any federal, state, or local public officials 19 Conferences, conventions, and meetings Interest 21 Payments to affiliates 22 Depreciation, depletion, and amortization Insurance . Other expenses. Itemize expenses not covered above. (List miscellaneous expenses in line 248. If line 24o amount exceeds 10% of line 25, column (A) amount, list line 243 expenses on Schedule 0.) a RESEARCH STUDIES 13,556,292. MEMBERSHIPS 13,237,107. ALL OTHER EXPENSE 1 511 517 . 1,388,732. All other expenses 25 Total functional expenses. Add lines 1 through 24o 2 07 941 637 . 26 Joint costs. Complete this line only if the organization reported in column (B) joint costs from a combined educational campaign and fundraising solicitation. Check here 'rl following sop sa-piasc sserzo: 432010 11-07-14 Form 990 (2014) 12 12161109 790809 53?0241211 2014.05000 PHARMACEUTICAL RESEARCH 8: 53?02411 PHARMACEUTICAL RESEARCH Sc MANUFACTURERS Form 990 {2014} OF AMERICA 53?0241211 Page 11 Part I Balance Sheet Check It Schedule 0 contains a response or note to any line in this Part .. .. . . . . m) (m Beginning of year End of year 1 Cash - non-interest-bearing 1 2 Savings and temporary cash investments Pledges and grants receivable, net 3 4 Accountsreceivable, net 2,248,529. 4 2,005,080. 5 Loans and other receivables from current and former officers, directors, trustees, key employees, and highest compensated employees. Complete PartllofScheduleL 200,000. 5 200,000. 6 Loans and other receivables from other disqualified persons (as defined under section 4958(f)(1)), persons described in section 4958(c)(3)(B), and contributing employers and sponsoring organizations of section 501(c)(9) voluntary 3 employees' beneficiary organizations (see instr). Complete Part II of 6 a 7 Notes and loans receivable, net 7 ?1 8 Inventories for sale or use 3 9 Prepaid expenses and deferred charges 10a Land. buildings, and equipment: cost or other basis. Complete Part VI of Schedule Less:accumulateddepreciation 10b 8,531,827. 3,144,987. 10c 3,695,197. 11 Investments - publicly traded securities Investments - other securities. See Part IV, line Investments - program-related. See Part IV, line 11 13 14 Intangible assets 14 15 Other assets. See Part IV, ine11 234, 720 . 15 214 612. 16 Total assets. Add lines1 throuqh15imusteoual line 34} 130 160 ,555 . 16 135 .545 781. 17 Accounts payable and accrued expenses Grants payable 18 19 Deferredrevenue 3,122,720- 19 3,925,775. 20 Tax-exempt bond liabilities 20 21 Escrow or custodial account liability. Complete Part IV of Schedule 21 2 Loans and other payables to current and former officers, directors, trustees, key employees, highest compensated employees, and disqualified persons. Complete Part II of Schedule 22 23 Secured mortgages and notes payable to unrelated third parties 23 24 Unsecured notes and loans payable to unrelated third parties 24 25 Other liabilities (including federal income tax, payables to related third parties, and other liabilities not included on lines 17-24). Complete Part of ScheduleD 28,435,181. 25 59,592,043. 26 Total liabilities. Add lines 17 through Organizations that follow SFAS 117 (A56 958), check here and 8 complete lines 27 through 29. and lines 33 and 34. 27 Unrestrictednetassets 83,731,994. 27 42,351,339. 28 Temporarily restricted net assets 28 29 Permanently restricted net aSSets 29 Organizations that do not follow SFAS 117 (A50 958), check here *5 and complete lines 30 through 34. .3 30 Capital stock or trust principal, or current funds 30 3 31 Paid-in or capital surplus, or land, building. or equipment fund 31 32 Retained earnings, endowment, accumulated income, or other funds 32 33 Totalnetassetsorfundbalances 83,731,994. 33 42,351,339. 34 Total liabilities and net assets/fund balan_ces 432011 11-07-14 12161109 13 790809 53?0241211 Form 990 (2014) 2014.05000 PHARMACEUTICAL RESEARCH 8: 53?02411 PHARMACEUTICAL RESEARCH Sc MANUFACTURERS Form 99012014] OF AMERICA Page 12 Part Xi Reconciliation of Net Assets Check if Schedule 0 contains a response or note to any line in this Part Xl 1 Total revenue (must equal Part column (A), line 12Total expenses (must equal Part IX, column (A), line 25Revenue less expenses. Subtract line 2 from line Net assets or fund balances at beginning of year (must equal Part X, line 33, column Net unrealized gains (losses) on investments Donated services and use of facilities 5 7 Investment expenses 7 8 Prior period adjustments 8 9 Other changes in net assets or fund balances (explain in Schedule Net assets or fund balances at end of year. Combine lines 3 through 9 (must equal Part X, line 3342,351,339- F?art Financial Statements and Reporting Check if Schedule 0 contains a response or note to any line in this Part XII . .. . . . . .. . . .1 Yes No 1 Accounting method used to prepare the Form 990: CI Cash Accrual Other If the organization changed its method of accounting from a prior year or checked "Other," explain in Schedule 0. 2a Were the organization's financial statements compiled or reviewed by an independent accountant? 2a If "Yes, check a box below to indicate whether the financial statements for the year were compiled or reviewed on a separate basis, consolidated basis, or both: Separate basis Consolidated basis Both consolidated and separate basis Were the organization's financial statements audited by an independent accountant? 2b If "Yes," check a box below to indicate whether the financial statements for the year were audited on a separate basis, consolidated basis, or both: :1 Separate basis Consolidated basis Both consolidated and separate basis If "Yes" to line 2a or 2b, does the organization have a committee that assumes responsibility for oversight of the audit, review, or compilation of its financial statements and selection of an independent accountant? 2c If the organization changed either its oversight process or selection process during the tax year, explain in Schedule 0. 3a As a result of a federal award, was the organization required to undergo an audit or audits as set forth in the Single Audit Act and OMB Circular 33 If "Yes," did the organization undergo the required audit or audits? If the organization did not undergo the required audit or_:_a_ydits, explain why in Schedule 0 and describe any steps taken to undergo such audits . . . .. .. . . 3b Form 990 (2014) 432012 11-07-14 14 12161109 790809 53?0241211 2014.05000 PHARMACEUTICAL RESEARCH 8: 53?02411 PHARMACEUTICAL RESEARCH MANUFACTURERS Schedule (Form 990) 2014 OF AMERICA Page 4 Part XI I Reconciliation of Revenue per Audited Financial Statements With Revenue per Return. Complete if the organization answered "Yes" to Form 9530, Part IV, line 12a. 1 Total revenue, gains, and other support per audited financial statements 1 2 Amounts included on line 1 but not on Form 990, Part line 12: a Net unrealized gains (losses) on investments 23 Donated services and use of facilities 2b 0 Recoveries of prior year grants 2c Other (Describe In Part 2d Add lines 2a through 2d 2e 3 Subtract line 2e from line 1 3 4 Amounts included on Form 990, Part line 12, but not on line 1: a Investment expenses not included on Form 990, Part line 7b 4a Other (Describe in Part Add lines 4a and 4b 4c 5 Total revenue Add lines Band 4mm?; ?l??t?a?ai?g?m 939 EggPart XII Reconciliation of Expenses per Audited Financial Statements With Expenses per Return. Complete if the organization answered "Yes" to Form 990. Part IV, line 12a. 1 Total expenses and losses per audited financial statements 1 2 Amounts included on line 1 but not on Form 990, Part IX, line 25- a Donated services and use of facilities 2a Prior year adjustments 2b Other losses 2c cl Other (Describe in Part 2d Add lines 2a through 2d 2e 3 Subtract line 2e from line 1 3 4 Amounts included on Form 990, Part IX, line 25, but not on line 1' a Investment expenses not included on Form 990, Part line 7b 4a Other (Describe in Part 4b Add lines 4a and 4b 4c 5 Total expenses. Add lines 3 and do. (This may 13,) . 5 Part Supplemental Information. Provide the descriptions required for Part II. lines 3,5, and 9; Part Iines1a and 4; Part IV, lines 1b and 2b: Part V, line 4; Part X, line 2; Part XI, lines 2d and 4b; and Part XII, lines 2d and 4b. Also complete this part to provide any additional information. PART X, LINE 2: PHRMA BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN, AND AS SUCH, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE FINANCIAL STATEMENTS. INCOME TAX RETURNS ARE GENERALLY SUBJECT TO EXAMINATION BY THE IRS FOR THREE YEARS AFTER THEY WERE FI LED . 13?2834 Schedule (Form 990) 2014 125 12161109 790809 53?0241211 2014.05000 PHARMACEUTICAL RESEARCH 53?02411 SCHEDULE Statement of Activities Outside the United States ?is-W (Form 990) Complete if the organization answered "Yes" on Form 990, Part IV, line 14b, 15, or 16. 4 Attach to Form 990. Open to Public Information about Schedule Form 990} and its instructions is at (is, goofing-H1990, Inspection Department of the Treasury Internal Revenue Service Name of the organization PHARMACEUTICAL RESEARCH Sc MANUFACTURERS OF AMERICA 53?0241211 I Part I I General Information on Activities Outside the United StateS. Complete if the organization answered "Yes" on Form 990, Part iine 14b. 1 For grantmakers. Does the organization maintain records to substantiate the amount of its grants and other assistance, the grantees' eligibility for the grants or assistance, and the selection criteria used to award the grants or assistance? Employer identification number i:i Yes No 2 For grantmakers. Describe in Part the organization's procedures for monitoring the use of its grants and other assistance outside the United States. 3 Activities per Region. [The {allowing Part I, line 3 table can be duplicated if additional space is needed.) Region Number of {Cl Number of Activities conducted in region If activity listed in Total offices Sg??ltusyien? (by type) fundraising, program is a program service, exi?fenditures in the region inde e?dent services, investments, grants to describe specific type . or and con raetors recipients located in the region) of Service(s) in region In region 9'0? MIDDLE EAST AND NORTH AFRICA 1 1 PROGRAM SERVICES MONITORS FOREIGN REGS 1,345 419 EAST ASIA AND THE PACIFIC 1 4 PROGRAM SERVICES MONITORS FOREIGN REGS 3 ,061 452. EUROPE (INCLUDING ICELAND GREENLAND) ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 GRANT MAKING 1,601, 453 EAST ASIA AND THE PACIFIC AUSTRALIA, BRUNEI, BURMA, CAMBODIA, 0 0 GRANT MAKING 1,191,437. NORTH AMERICA 7 CANADA AND MEXICO, BUT BUT NOT THE UNITED STATES 0 0 MAKING 215 646 MIDDLE EAST AND NORTH AFRICA ALGERIA, BAHRAIN, DJIBOUTI, EGYPT 0 GRANT MAKING 68 ,500, SOUTH AMERICA ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR, 0 BRANT MAKING 215 83 7 RUSSIA AND NEIGHBORING STATES 0 0 GRANT MAKING 85, 000. 3a Sub-total 2 5 7,784,744. Total from continuation sheetsto Partl 0 0 374.207. 0 Totals (add lines 33 3.1.3313} 2 5 8,158,951. LHA For Paperwork Reduction Act Notice, see the Instructions for Form 990. Schedule (Form 990) 2014 432071 09-24?14 126 12161109 790809 53?0241211 2014.05000 PHARMACEUTICAL RESEARCH 8: 53?02411 PHARMACEUTICAL RESEARCH 8: MANUFACTURERS Schedule [Form 990) OF AMERICA 53?0241211 pan? Part I Continuation of Activities per Region. {Schedule (Form 990), Part I. line 3) Region Number of Number of Activities conducted in region If activity listed in Total offices employees or (by type) fundraising. iS a program service, expenditures in the region agents in program services, grants to describe specific type for region region recipients located in the region) of service(s) in region SOUTH ASIA 0 0 GRANT MAKING 374, 207. Totals 432181 05-01-14 1 2 '7 12161109 790809 53?0241211 2014.05000 PHARMACEUTICAL RESEARCH 8: 53?02411 PHARMACEUTICAL RESEARCH MANUFACTURERS Schedule {Form 990: 2014 OF AMERICA 53-0241211 Page 2 I Part II Grants and Other Assistance to Organizations or Entities Outside the United States. Complete if the organization answered "Yes" on Form 990. Part IV, line 15, for any recipient who received more than $5,000. Part II can be duplicated if additional space is needed. 1 IRS cod t? Name of organization 9 Sec 10? and EIN (if applicable) Purpose of grant Amount Manner of of cash grant cash disbursement (9) Amount of assistance Description Method of of non-cash valuation (book. FMV. assistance appraisal. other) SOUTH AMERICA SUPP. FOR THE 9TH AILANZA LATINA FORUM EAST ASIA AND THE PACIFIC GRANT FOR ALZHEIMER UNIV TRAINING COURSE IN GENEVA EUROPE FOR THE CONTINUATION PROJECT BY AIFD IN TURKEY AMERICA SPONSORSHIP FOR NACIC CONFERENCE IN TORONTO, OCT 30-31, 14 EIDDLE EAST AND ORTH AFRICA SUPPORT TO ESTABLISH A PHARMACEUTICAL COMMITTEE OUTH AMERICA FUNDING FOR CARLOS FERNANDEZ DAVILA SERVICES 30'000. NIRE NORTH AMERICA GRANT FOR THE HEALTHCARE BUDGET IN MEXICO SOUTH AMERICA BRAZILIAN REG POLICY RESEARCH PROJ 2 Enter total number of recipient organizations listed above that are recognized as charities by the foreign country. recognized as tax-exempt by the or for which the grantee or counsel has provided a section 501(c)(3) equivalency letter 3 Enter total number of other organizatmns or entities 432072 09-24-14 2128 b? 0 24 Schedule (Form 990) 2014 PHARMACEUTICAL RESEARCH MANUFACTURERS Schedule [Form 990] OF AMERICA Part i Continuation of Grants and Other Assistance to Organizations or Entities Outside the lJn?ed States{Schedule [Form 990]. Part II. line 1} Page 2 1 IRS code section Name of organization and EIN (if applicable) Purpose Of grant Amount Fie ion of cash grant (9) Amount Of non-cash assistance Manner of cash disbursement Description of non-cash assistance Method of vaiuation (book, FMV, appraisal. other) 2014 GRANT T0 CDRF PHRMA SPONSORED EAST ASIA AND THE DIALOGUE PACIFIC 336,465. WIRE 0. NORTH AMERICA APEC PROJECT 10,545. NIRE 0, GRANT FOR SUPPORTING CHALLENGES OPPORT IN CHINESE REG ENV EUROPE 35,500_ WIRE 0, 3TH ANN EUROPEAN EUROPE SUPPORT 50.000. WIRE U. 2014 GRANT GLOBAL EUROPE IP ACTION PLAN 313,000. WIRE 0. GRANT FOR 2014 MTG EAST ASIA AND THE PACIFIC 25,000, WIRE 0 . CONDUCT LITERATURE ON ACCESS TO MEDICINE EUROPE 948,311. WIRE U. GRANT -TACKLING CHRONIC DISEASES IN INDIA INSTL MIDDLE EAST AND NORTH AFRICA 374,207. WIRE U. RUSSIA NEWLY INDEPENDENT STATES GRANT TO SUPPORT INNOVATIVE PHARMA CTIVITIES 85,000. HIRE 0 . 432182 05-01-14 129 PHARMACEUTICAL RESEARCH MANUFACTURERS Schedule (Form 990?] OF AMERICA Part II I Continuation of Grants and Other Assistance to Organizations or Entities Outside the II 53?0241211 Jriited St_ates. {Scheduie {Form 990]. Part ii. line 1} Page 2 1 8 code tion Name of organization IR 5 and EIN (if applicabie) Purpose of grant Amount Re ion (6) of cash grant Manner of cash disbursement (9) Amount of non-cash assistance Description of non-cash assistance Method of valuation (book, FMV, appraisai, other) IAPO LATIN AMERICAN REGIONAL PROGRAM EUROPE 14l_415. WIRE PHRMAJ PAPER 0N VACCINES RISK PERCEPTION 9/1-9/30/13 EUROPE 51000. WIRE MIDDLE EAST AND NORTH AFRICA HIS CONTRAT PROGRAM CONTRIBUTION 35,000, HIRE 2014 GRANT FOR EAST ASIA AND THE HEALTHCARE REFORM PACIFIC PROJECT 710.972. WIRE SPONSORSHIP GLOBAL FORUM, LONDON UK 2014 EUROPE 22,227, WIRE SUPPORT SEPHIRE EIDDLE EAST AND SOVERNMENT PRICING ORTH AFRICA 15,000. HIRE CONTRIBUTION TO THE APAC HEALTH EAST ASIA AND THE PRODUCTIVITY STUDY ACIFIC 54,000_ WIRE 432182 05?01-14 13() PHARMACEUTICAL RESEARCH MANUFACTURERS Schedule (Form 990) 2014 OF AMERICA Paqe 3 Part Grants and Other Assistance to Individuals Outside the United States. Complete if the organization answered "Yes" on Form 990, Part IV, line 16. Part can be duplicated if additional space is needed. Number of Amount of Manner of Amount of (9) Description of Method of recipients cash grant cash disbursement non-cash non-cash assistance valuation assistance (bookI FMV, appraisal. other} Type of grant or assistance Region Schedule (Form 990) 2014 432073 09-24-14 131 PHARMACEUTICAL RESEARCH MANUFACTURERS Schedule [Firm 99012014 OF AMERICA 53?0241211 Pager: 3'1 I Foreign Forms 1 Was the organization a U.S. transferor of property to a foreign corporation during the tax year? if "Yes, the organization may be required to file Form 926, Return by a US. Transferor of Property to a Foreign Corporation (see Instructions for Form 926) El Yes No 2 Did the organization have an interest in a foreign trust during the tax year? if "Yes, the organization ma?be required to Form 3520, Annual Return To Report Transactions With Foreign Trusts and Receipt of Certain Foreign Gifts, and/or Form Annual information Return of Foreign Trust With a U. 8. Owner (see instructions for Forms 3520 and do not file with Form 990) Yes N0 3 Did the organization have an ownership interest in a foreign corporation during the tax year? if ?yes, the organization may be required to file Form 5471. information Return of US. Persons With Respect To Certain Foreign Corporations (see instructions for Form 54 71) El Yes No 4 Was the organization a direct or indirect shareholder of a passive foreign investment company or a qualified electing fund during the tax year? if "Yes, the organization may be required to file Form 8621, information Return by a Shareholder of a Passive Foreign investment Company or Quali?ed Electing Fund (see instructions for Form 8621) 1: YES NO 5 Did the organization have an OWnership interest in a foreign partnership during the tax year? if "Yes, the organization may be required to file Form 8865, Return of US Persons With Respect to Certain Foreign Partnerships (see instructions for Form 8865) I: No 8 Did the organization have any operations in or related to any boycotting countries during the tax year? if "Yes," the organization may be required to file Form 5 713, international Boycott Report (see instructions for Form 5713; do not file with Form 990) Yes No Schedule (Form 990) 2014 432074 09-24-14 132 12161109 790809 53?0241211 2014.05000 PHARMACEUTICAL RESEARCH 53?02411 PHARMACEUTICAL RESEARCH MANUFACTURERS Schedule {Form 99012014 OF AMERICA Page 5 I Part I Supplemental Information Provide the information required by Part I, line 2 (monitoring of funds); Part I, line 3, column (accounting method; amounts of investments vs. expenditures per region); Part II, line 1 (accounting method); Part (accounting method); and Part column (estimated number of recipients), as applicable. Also complete this part to provide any additional information. PART I, LINE 2: DEPENDING ON THE NATURE AND PURPOSE OF THE GRANT, PHRMA MAY REQUIRE THE RECIPIENT OF A GRANT TO SUBMIT PERIODIC REPORTS OR SIMILAR DOCUMENTATION TO VERIFY THAT THE GRANT IS BEING USED APPROPRIATELY FOR THE INTENDED USE. IN GENERAL, UNLESS THE GRANT IS USED TO SUPPORT A SPECIFIC EFFORT OR PROJECT, THEN NO ADDITIONAL FORMAL MONITORING MAY BE INVOLVED BEYOND ENSURING APPROPRIATE DOCUMENTATION OF THE GRANT AND LEGITIMACY OF THE RECIPIENT ORGANIZATION. IRRESPECTIVE OF THE NATURE OR PURPOSE OF THE GRANT, PHRMA AWARDS GRANTS BASED ON THE UNDERSTANDING THAT RECIPIENTS ARE RESPONSIBLE FOR ENSURING THAT GRANTS ARE USED FOR PROPER PURPOSES AND IN COMPLIANCE WITH ALL LEGAL REQUIREMENTS. 432075 09-24-14 Schedule (Form 990) 2014 1 3 3 12161109 790809 53?0241211 2014.05000 PHARMACEUTICAL RESEARCH 53?02411 OMB No. 1545?0047 2014 Open to Public Inspection SCHEDULEI Grants and Other Assistance to Organizations, iF?rm 99?) Governments, and Individuals in the United States Complete if the organization answered "Yes" to Form 990, Part IV, line 21 or 22. Department ofthe Treasury Attach to Form 990. mm? Raven? Information about Schedule 1 Form 990 and its instructions is at mm {m aovrrormgga Name of the organization PHARMACEUTICAL RESEARCH 8: MANUFACTURERS Employer identi?cation number OF AMERICA 53-0241211 I Part I I General Information on Grants and Assistance 1 Does the organization maintain records to substantiate the amount of the grants or assistance, the grantees? eligibility for the grants or assistance, and the selection criteria used to award the grants or assistance? I I Yes No 2 Describe in Part IV the organization's procedures fer monitoring the use of grant funds in the United States. Part I Grants and Other Assistance to Domestic Organizations and Domestic Governments. Complete if the organization answered "Yes" to Form 990. Part IV, me 21, for any recipient that received more than 55.000. can be duplicated if additional space is needed. 1 Name and address of organization EIN IRC section Amount of Amount of MgthOd 0f (9) Description of Purpose of grant or government if applicable cash grant non-cash va?uat'on (book? non-cash assistance or assistance I FMV, appraisal, other) 2015 ARIZONA GOVERNMENT TRANSITION 2201 CAMELBACK ROAD STE 220 A AZ 85016 47?2237693 MEMBERSHIP 0 10,000. 0, COTWRIE-POLITICAL ADVOCATES FOR YOUTH 2000 STREET NW STE 750 DC 20036 52?1173590 CHARITABLE 0 10,000. 0, CONTRIB-GENERAL AIDS INSTITUTE INC 17 DAVIS BLVD STE 403 TAMPA, FL 33606 65-0380952 CHARITABLE 0 100,000, 0, COETRIB-GENERAL ALLIANCE FOR AGING RESEARCH 1700 STREET Nw STE 740 WASHINGTON. DC 20006 54-1379174 CHARITABLE 0 25,000. 0, .5 GENERAL ALLIANCE FOR HEALTHCARE COMPETITIVENESS 888 17TH STREET NW STE 1200 - DC 20005 52?2123021 LLC 50,000. 0, CONTEIE-EVENT GENERAL ALLIANCE FOR PATIENT ACCESS PO BOX 670 BETTENDORFI IA 52722 20-5130312 .MEMBERSHIP 0 55,000. 0. 2 Enter total number of section 501(c)(3) and government organizations listed in the line 1 table I. 2 0 '5 - 3 Entertotal number ofother organizations listed in the "net table . .. .. .. . .. .. . . . . . . . .. 84 LHA For Paperwork Reduction Act Notice, see the Instructions for Form 990. SChedUle I (Form 990) (2014) 432101 10?15-14 134 PHARMACEUTICAL RESEARCH MANUFACTURERS SchedueilForm 990) OF AMERICA 53-0241211 Page.? Part II Continuation of Grants and Other Assistance to Governments and Organizations in the United States [Schedule I {Form 990), Part Name and address of EIN section Amount of Amount of Method of (9) Description of Purpose of grant organization or government if applicable cash grant non~cash valuation non-cash assistance or assistance assistance (bookI FMVI appraisal. other) ALS ASSOCIATION CAPITAL OFFICE 1275 ST NW STE 250 WASHINGTON: DC 20005 13?3271855 CHARITAB 50.000. 0, GENERAL ALS ASSOCIATION GOLDEN WEST CHAPTER INC PO BOX 555 - AGOURA HILLS. CA 91375 95?4163338 CHARITAB 10,000. 0. GENERAL ALTA MED HEALTH SERVICES CORPORATION 5211 WASHINGTON BLVD STE 2?186 COMMERCE, CA 90040 95?2810095 CHARITAB 10,000. 0. ALZHEIMERS ASSOCIATION WESTERN CENTRAL 100 HARRISON ST STE 200 - WA 98119 13?3039601 CHARITAB 25,100. 0. CONTRIB-EVENT GENERAL AMERICA NEXT INC PO BOX 320966 ALEXANDRIA. VA 22320 46-3681383 MEMBERSH 50'000_ 0. CONTRIB-GENERAL AMERICAN ACADEMY OF FAMILY PHYSICIANS FOUNDATION - 11400 TOMAHAWK CRK PKWY STE 440 KS 56211 44?6013671 CHARITAB 35,000+ 0, CONTRIB-GENERAL AMERICAN ACADEMY OF PEDIATRICS 141 NORTHWEST POINT BOULEVARD ELK GROVE VILLAGE, IL 50007 36-2275597 CHARITAB 180,000. 0. CONTRIB-GENERAL AMERICAN ACTION FORUM 1747 AVE NW 5TH FLOOR WASHINGTON. DC 20005 27?0567765 CHARITAB 125,000. 0. CONTRIB-GENERAL AMERICAN ASSOCIATION OF PEOPLE WITH DISABILITIES 2013 STREET NW 5TH FL WASHINGTON, DC 20006 52?1930174 501(c)3 CHARITAB 25,000. 0. CONTRIB-GENERAL Schedule I (Form 990) 432241 05-01-14 135 PHARMACEUTICAL RESEARCH MANUFACTURERS Schedule [Form 990) OF AMERICA 1 Part II Continuation of Grants and Other Assistance to Governments and Organizations in the United States {Schedule I (Form 990). Part II.) 53-0241211 Paqet Name and address of organization or government EIN (0) section if applicable Amount of cash grant Amount of Purpose of grant or assistance if) Method of valuation (book, FMV, appraisal, other) (9) Description of non-cash non-cash assistance assistance AMERICAN CANCER SOCIETY PORTLAND OFFICE 0330 SW CURRY ST PORTLAND. OR 97239 13?1788491 CHARITAB 9,500. 0. AMERICAN COLLEGE OF PREVENTIVE MEDICINE - 455 MASSACHUSETTS AVE NW STE 200 DC 20001?2521 23?1722119 CHARITAB 15,000. 0 CONTRIB-GENERAL AMERICAN COMMITMENT 1300 PENN AVE NW STE 190 406 DC 20004 45?2600535 MEMBERSH 50,000. 0. CONTRIE-GENERAL AMERICAN DIABETES ASSOCIATION 4600 ROSEVILLE RD STE 130 NORTH HIGHLANDS: CA 95660 13?1623888 CHARITAB 7,500_ 0. CONTRIBAGENERAL AMERICAN HEART ASSOCIATION UTAH CHAPTER 455 SOUTH 400 EAST STE 110 - SALT LAKE CITY, UT 84111 13?5613797 i501(C)3 CHARITAB 10?000. 0. AMERICAN LEGISLATIVE EXCHANGE COUNCIL - 2900 DRIVE 6TH FLOOR ARLINGTON. VA 22202 52?0140979 CHARITAB 136,500, 0. GENERAL AMERICAN LIVER FOUNDATION 5777 WEST CENTURY BLVD STE 865 LOS CA 90045 36?2883000 CHARITAB 3,500. 0. CONTRIE-GENERAL AMERICAN MEDICAL ASSOCIATION FOUNDATION 330 NORTH WABASH AVE STE 39300 CHICAGO, IL 60611?5885 36?6080517 CHARITAB 40,000, 0 AMERICAN MEDICINE CHEST CHALLENGE 155 MILLBURN AVE MILLBURN, NJ 07041 27-2484883 CHARITAB 75,000. 0. 432241 05-01?14 1L36 Schedule I (Form 990) PHARMACEUTICAL RESEARCH MANUFACTURERS Schedule I [Form 990} OF AMERICA I Part Continuation of Grants and Other Assistance to Governments and Organizations in the United States {Schedule I [FOrm 990}, Part 53-0241211 Paqe1 Name and address of EIN IRC section Amount Of Amount of non-cash Method of valuation (9) Description of non-cash assistance Purpose of grant or assistance organization or government if applicable cash grant assistance (book, FMV, appraisal, other) AMERICAN MIDDLE EAST INSTITUTE 5 VON LENT PLACE PITTSBURGH, PA 15232 26?3562819 CHARITAB 50,000. AMERICAN OSTEOPATHIC FOUNDATION 142 ONTARIO ST STE 1450 CHICAGO, IL 60611 36?6056120 CHARITAB 30,000. AMERICANS FOR A BALANCED BUDGET 0 BOX 25508 RALEIGH, NC 27511 01?0916403 MEMBERSH 100,000, AMERICANS FOR PROSPERITY 2111 WILSON BOULEVARD STE 350 ARLINGTON, VA 22201 75?3148958 MEMBERSH 15,000, CONTRIB-GENERAL AMERICANS FOR TAX REFORM 722 12TH ST NW 4TH FLR WASHINGTON, DC 20005 52?1403587 MEMBERSH 105,000. ANDREW CHRISTIAN BRYCE FOUNDATION 9 DUNCAN LANE TROY, NY 12180 14?1825108 CHARITAB 5,000, CENTRES-GENERAL ARTHRITIS FOUNDATION 35 COLD SPRING RD STE 411 ROCKY HILL, CT 05067 06?0672782 CHARITAB 11,500. CONTRIB-GENERAL ARTHRITIS FOUNDATION NEW ENGLAND REGION 2348 POST ROAD STE 104 WARWICK, RI 02885 04?2113261 CHARITAB 39,100. CONTRIBHGENERAL ASIAN PACIFIC ISLANDER AMERICAN HEALTH FORUM ONE KAISER PLAZA STE 850 OAKLAND, CA 94612 94?3030856 CHARITAB 10,000. 432241 05-01-14 1257 Schedule I (Form 990) CONTRIB-EVENT GENERAL PHARMACEUTICAL RESEARCH MANUFACTURERS OF AMERICA Schedule {Form 990] 53-0241211 Page?l I Part II I Continuation of Grants and Other Assistance to Governments and Organizations in the United States {Schedule I {Form 990}. Part II.) Name and address of organization or government IRC section if applicable Amount of cash grant Amount of (9) Description of non-cash assistance Purpose of grant or assistance if) Method of valuation (book. FMV, appraisal, other) non-cash assistance ASIAN PACIFIC AMER INST FOR CONGRESS STUDIES 1001 CONNECTICUT AVE NW STE 320 DC 20035 45?5177589 MEMBERSH 10,000. 0. CONTRIB-GENERAL ASSN OF STATE AND TERRITORIAL HLTH OFFICIALS DR STE 450 VA 22202 35?1044487 CHARITAB 60,000, 0. CONTRIB-GENERAL ASTHMA AND ALLERGY FOUNDATION OF AMERICA 8201 CORPORATE DR STE 1000 MD 20785 13?1691693 CHARITAB 10_000. 0. AUTISM SPEAKS 1990 STREET NW 2ND FLOOR WASHINGTONJ DC 20005 20?2329938 CHARITAB 0,750. 0, AUTOIMMUNE DISEASES ASSOCIATION 22100 GRATIOT AVENUE MI 48021 38?3027574 CHARITAE 45,000. 0. CONTRIBLGENERAL INAUGURAL COMMITTEE 1505 COMMONWEALTH AVE 5TH FLOOR BRIGHTON, MA 02135 47?2283861 MEMBERSH 25.000. 0. CONTRIB-GENERAL BAY AREA BIOSCIENCE ASSOCIATION 250 EAST GRAND AVENUE STE 26 SOUTH SAN FRANCISCO) CA 94050 20?4115716 TRADE AS 50,000. 0_ BIOFLORIDA INC 525 OKEECHOBEE BLVD STE 1500 WEST PALM BEACH, FL 33401 59?3436638 TRADE AS 9,000. 0. GENERAL BIOTECHNOLOGY INDUSTRY ORGANIZATION 1201 MARYLAND AVE SW SUITE 900 - DC 20024 52?1224577 TRADE AS 73,513. D, 432241 05-01-14 1238 Schedule I (Form 990) PHARMACEUTICAL RESEARCH St MANUFACTURERS Schedule I [Form sen: OF AMERICA 5 3?0 241211 Page I Part Continuation of Grants and Other Assistance to Governments and Organizations in the United States (Schedulel (Form 9901. Part In Name and address of EIN IRC section Amount of Amount of Method of (9) Description of Purpose of grant organization or government if applicable cash grant non-cash valuation non-cash assistance or assistance assistance (book, FMV, appraisal, other) BIOTECHNOLOGY INSTITUTE 1201 MARYLAND AVE STE 900 WASHINGTON, DC 20024 25?1715917 CHARITAB 40,000. 0- CONTRIB-GENERAL BOYS AND GIRLS CLUB OF GREATER WASHINGTON INC 4103 BENNING RD NE WASHINGTON, DC 20019 53?0235759 CHARITAB 10,000. 0, CONTRIB-GENERAL BRIGHAM AND WOMENS HOSPITAL INC PO BOX 3149 MA 02241?3149 04?2312909 CHARITAB 65,000, 0, CONTRIE-GENERAL BRYCE HARLOW ANNUAL AWARD DINNER PO BOX 75652 MD 21275?5652 52~1265620 CHARITAB 10,000. 0. CONTRIB-GENERAL BUSINESS COUNCIL FOR INTERNATIONAL UNDERSTANDING 1212 AVE OF THE AMERICAS 10TH FL - NEW YORK, NY 10035 13?6151195 CHARITAB 68,500. 0. GENERAL CALIFORNIA CHRONIC CARE COALITION 909 12TH ST STE 201 SACRAMENTO. CA 95814 45?3074708 CHARITAE 50,000, 0 CALIFORNIA HEALTHCARE INSTITUTE 1608 RHODE ISLAND AVE 2ND FLOOR DC 20036 94-3174767 MEMBERSH 15'000. 0. GENERAL CALIFORNIA ISSUES FORUM 1127 11TH ST SUITE 331 SACRAMENTO, CA 95814 01?0595129 MEMBERSH 30.000. 0. CONTRIE-GENERAL CALIFORNIA STATE CONFERENCE OF THE NAACP - 1215 ST STE 1509 SACRAMENTO. CA 95814 95?4617376 CORPORATION 25,000, 0. Schedule (Farm 990) 432241 05-01-14 139 PHARMACEUTICAL RESEARCH MANUFACTURERS Schedu I [Form 990} OF AMERI Paqe 1 I Part II Continuation of Grants and Other Assistance to Governments and Organizations in the United States {Schedule I {Form 990}. Part II.) Name and address of EIN section Amount of Amount of Method of (9) Description of Purpose of grant organization or government if applicable cash grant non-cash valuation non-cash assistance or assistance assistance (book, FMV, appraisal, other) CANCER SUPPORT COMMUNITY 1050 17TH STREET NW STE 500 DC 20036 95?4163931 CHARITAB 11,000. 0. CONTRIB-EVENT GENERAL CAREGIVER ACTION NETWORK 2000 ST NW SUITE 400 DC 20035 52-1780405 CHARITAB 315,000. 0. GENERAL CAROLINA PARTNERSHIP FOR REFORM INC 9660 FALLS OF NEUSE ROAD STE 138 208 - RALEIGH, NC 27614 46?2332524 501(c)4 MEMBERSH 25,000, 0. CONNIE-GENERAL CENTER FOR AMERICAN PROGRESS ACTION FUND - 1333 ST NW 10TH FLOOR DC 20005 30?0192708 MEMBERSH 25,000. 0_ CENTER FOR MEDICINE IN THE PUBLIC INTEREST 757 THIRD AVE 20TH FLOOR NEW NY 10017 20?4321812 CHARITAB 75,000. 0. CONTRIB-GENERAL CENTER FOR STRATEGIC INTERNATIONAL STUDIES Po BOX 826396 PHILADELPHIA, PA 19182?6396 52?1501082 CHARITAB 52,000, 0. CHILDRENS CHARITIES FOUNDATION INC 3000 ST NW STE 600 WASHINGTON, DC 20007 52?1907059 CHARITAB 28,000. 0. CONTRIB-EVENT GENERAL CHILDRENS INN AT NIH 5910 GLOSTER ROAD MD 20816 52?1638207 CHARITAB 15_000_ 0, CHPD NASHP 10 FREE STREET 2ND FLOOR ME 04101 52?1576801 CHARITAB 15,000. 0. CONTRIB-EVENT GENERAL Schedule I (Form 990) 432241 05?01-14 14() PHARMACEUTICAL RESEARCH MANUFACTURERS OF AMERICA Schedule i [Form 990] 53-0241211 I Part Continuation of Grants and Other Assistance to Governments and Organizations in the United States {Schedule {Form 990}. Part ii.) Page Name and address of organization or government EIN IRC section if applicable Amount Of cash grant Amount Of non-cash assistance Method Of valuation (book, FMV, appraisal, other) (9) Description of non-cash assistance Purpose of grant or assistance COMMITTEE FOR ECONOMIC DEVELOPMENT 2000 STREET NW STE 700 WASHINGTON, DC 20036 13?1623973 CHARITAB 25,000, CONTRIB-GENERAL COMMON GOOD VA PO BOX 101507 ARLINGTON, VA 22210 46?5033171 CHARITAB 10,000. CONTRIE-GENERAL COMMUNITY ANTI DRUG COALITION OF AMERICA 625 SLATERS LANE STE 300 VA 22314 54?1610317 CHARITAB 7,500. GENERAL COMMUNITY HEALTH CHARITIES OF IOWA 600 MARTIN LUTHER KING PKWY DES NOINES, IA 50312 42?1484988 CHARITAB 31,000. COMMUNITY LEADERS OF AMERICA 1005 CONGRESS AVENUE STE 350 AUSTIN, TX 78701 46?3149989 527 POLITICAL 0R 10,000. CONTRIB-POLITICAL COMPETITIVE ENTERPRISE INSTITUTE 1899 ST NW 12TH FL WASHINGTON, DC 20036 52?1351785 CHARITAB 15,000. GENERAL CONFERENCE OF WESTERN ATTORNEYS GENERAL 1300 I STREET SACRAMENTO, CA 95814 68?0250561 CHARITAB 25,000. CONTEIB-EVENT a GENERAL CONGRESS BLACK CAUCUS POL EDUC LEADERSHIP INST 413 NEW JERSEY AVE SE - DC 20003 52?2270607 MEMBERSH 10,000. CONTRIE-GENERAL CONGRESSIONAL AWARD FOUNDATION PO BOX 77440 WASHINGTON, DC 20013 52?1168592 CHARITAB 10,000, CONTRIB-GENERAL 432241 05-01-14 Ju42 Schedule 1 (Form 990) PHARMACEUTICAL RESEARCH Sc MANUFACTURERS Schedule {Form 930} OF AMERICA 5 3? 0241211 Page?l Part Continuation of Grants and Other Assistance to Governments and Organizations in the United States [Schedule {Form 990}. Part ll.) Name and address of section Amount of Amount of Method of (9) Description of Purpose of grant organization or government if applicable cash grant non-cash valuation non-cash assistance or assistance assistance (book, FMV, appraisal, other) CITIZENS AGAINST GOVERNMENT WASTE 1301 AVE NW STE 1075 DC 20004 52-1363952 CHARITAB 15,000. 0. CONTRIB-EVENT GENERAL CITIZENS FOR CHRISTINE RADOGNO PO BOX 3422 SPRINGFIELD, IL 62708 36-4207961 527 POLITICAL OR 7,500. 0. CONTRIB-POLITICAL CITIZENS FOR DURKIN 16 W281 83RD STREET STE BURR IL 60527 36?4002366 527 POLITICAL OR 7,500_ 0, COETRIB-POLITICAL CITIZENS FOR JOHN CULLERTON 29 LASALLE ST SUITE 936 IL 60603 36?3091417 527 POLITICAL OR 10,500. 0. CONTRIB-POLITICAL CITY COUNTY OF SAN FRANCISCO SF ENVIRONMENT 1455 MARKET STREET 12TH FLOOR - SAN FRANCISCO, CA 94103 94~6000417 GOVT AGENCY 32,500. 0. CONTRIB-GENERAL COALITION FOR CLINICAL TRIALS AWARENESS PO BOX 670 IA 52722 46-4244156 CORPORATION 25?000. 0. CONTRIE-GENERAL COALITION OF STATE RHEUMATOLOGY ORGANIZATIONS - 1100 WOODFIELD ROAD STE 350 SCHAUMBURG, IL 60173 32?0093904 CHARITAB 25,000. D, CONTRIB-GENERAL COLON CANCER ALLIANCE 1025 VERMONT AVE NW STE 1066 WASHINGTON: DC 20005 86-0947831 CHARITAE 25_000. 0, CONTRIB-GENERAL COLORADO ASSOCIATION OF COMMERCE AND INDUSTRY 1600 BROADWAY STE 1000 DENVERI co 80202 84?0174402 TRADE AS 12,400. 0, CONTRIB-GENERAL Schedule I (Form 990) 432241 05-01-14 141 PHARMACEUTICAL RESEARCH MANUFACTURERS Schedule I [Form 990} OF AMERICA 53_0241211 Pa 81 [Part Continuation of Grants and Other Assistance to Governments and Organizations in the United States {Schedule (Form 990}. Part II.) Name and address of EIN IRC section Amount of Amount of Method of (9) Description of Purpose of grant organization or government if appiicable cash grant non-cash valuation non-cash assistance or assistance assistance (book. FMV. appraisal, other) CONGRESSIONAL COALITION ON ADOPTION INSTITUTE 311 MASSACHUSETTS AVE NE WASHINGTON, DC 20002 54?2035617 CHARITAB 10,000. 0. CONGRESSIONAL HISPANIC CAUCUS INSTITUTE 300 STREET SE SUITE 510 WASHINGTON, DC 20003 52?1114225 CHARITAB 25,000, 0. CONTRIE-GENERAL CONNECTICUT RETAIL MERCHANTS ASSOCIATION 60 FOREST ST CT 05105 05?6079119 TRADE AS 5,500. 0. CONTRIB-EVENT GENERAL CONSERVATIVE PRINCIPLES FOR FLORIDA PC 95 MERRICK WAY STE 250 - CORAL GABLES, FL 33134 45?3640598 527 POLITICAL OR 8,500. 0. CONTRIB-POLITICAL COOL KIDS CAMPAIGN FOUNDATION INC 8422 BELLONA LANE STE 102 TOWSON, MD 21204 42-1534330 CHARITAB 10,000. 0. CONTRIB-EVENT GENERAL COUNCIL ON AGING 0F GREATER NASHVILLE 95 WHITE BRIDGE RD STE 114 NASHVILLE, TN 37205 62?1687122 CHARITAB 6,000, 0. CTR FOR INFO STUDY ON CLINICAL RESEARCH PARTICIP 55 COMMERCIAL WHARF EAST - BOSTON. MA 02110 20?0588190 CHARITAB 76,500. 0. CONTRIB-GENERAL CYSTIC FIEROSIS FOUNDATION 5931 ARLINGTON ROAD STE BETHESDA, MD 20814?4288 13?1930701 CHARITAB 35,000, 0. CONTRIH-EVENT GENERAL DAVID A WINSTON HEALTH POLICY FELLOWSHIP 2000 14TH ST NORTH STE 780 - ARLINGTON. VA 22201 52?1492039 CHARITAB 22.000. 0, GENERAL Schedule 1 (Form 990) 432241 05-01?14 143 PHARMACEUTICAL RESEARCH MANUFACTURERS OF AMERICA Schedule I {Form 990) 53?0241211 I Part II I Continuation of Grants and Other Assistance to Governments and Organizations in the United States (Schedule [Form 990), Part Page 1 Name and address of organization or government EIN IRC section if applicable Amount of cash grant Amount of non-cash assistance Method of valuation (book. FMV, appraisal, other) (9) Description of non~cash assistance Purpose of grant or assistance DC DESIGN HOUSE INC 4933 MACARTHUR BLVD NW WASHINGTON, DC 20007 26?3817892 CHARITAE 25,000. DEMOCRATIC ASSEMBLY CAMPAIGN 195 WEST STATE STREET TRENTONII NJ 08608 20-4354327 527 POLITICAL DR 7,500, CONTRIB-POLITICAL DEMOCRATIC ASSEMBLY CAMPAIGN COMMITTEE 107 WASHINGTON AVE STE 1 LL NY 12210 13?3041656 POLITICAL COMMIT 30,000, CONTRIB-POLITICAL DEMOCRATIC GOVERNORS ASSN 1401 STREET NW STE 200 WASHINGTON, DC 20005 52?1304889 POLITICAL COMMIT 475,000. CONTRIB-POLITICAL DEMOCRATIC LEGISLATIVE CAMPAIGN COMMITTE 1401 STREET NW STE 201 WASHINGTON. DC 20005 52?1870839 527 POLITICAL OR 100,000, CONTRIB-POLITICAL DIGITAL CITIZENS ALLIANCE 1150 17 TH ST NW SUITE 700 DC 20036 45?0820995 TRADE AS 20,000. DOMINION LEADERSHIP TRUST PAC 106 CARTER STREET VA 22405 05?0524341 527 POLITICAL OR 6,500. CONTRIB-POLITICAL EAGLE PAC 801 ADAMS AVE MONTGOMERY. AL 35541 63?1270419 POLITICAL COMMIT 17,750. EASTER SEALS INC 230 MONROE ST STE 1800 CHICAGO, IL 50505 36?2171729 CHARITAB 250,000. GENERAL 432241 05-01-14 2144 Schedule (Form 990) PHARMACEUTICAL RESEARCH MANUFACTURERS OF AMERICA Schedule (Form 990} 53-0241211 Page?l I Part Continuation of Grants and Other Assistance to Governments and Organizations in the United States {Schedule {Form 990}. Part Name and address of organization or government EIN IRC section if applicable (cl) Amount of cash grant (9) Description of non-cash assistance Purpose of grant or assistance Amount of non-cash assistance Method of valuation (book, FMV, appraisal, other) ECONOMIC CLUB OF WASHINGTON DC 1156 15TH ST NW STE 600 WASHINGTON, DC 20005 52-1469926 CHARITAB 6,000. 0. GENERAL EPILEPSY FOUNDATION 8301 PROFESSIONAL PL - STE 200 LANDOVERI MD 20735 52?0855660 CHARITAE 25,000. a, ETHICS AND PUBLIC POLICY CENTER 1730 STREET NW SUITE 910 WASHINGTON, DC 20036 52?1162185 CHARITAB 25,000. 0. EVERYLIFE FOUNDATION FOR RARE DISEASES 77 DIGITAL DRIVE SUITE 210 NOVATO, CA 94949 26?4614274 CHARITAB 10,000, 0. GENERAL FEDERAL CITY COUNCIL 1156 15TH STREET NW SUITE 600 WASHINGTON, DC 20005 53?0219643 CHARITAB 50,000. 0. CONTRIB-GENERAL FIRST TEE 0F SILICON VALLEY 1922 THE ALAMEDA STE 214 SAN JOSE, CA 95126 46?3102278 CHARITAB 17,500, 0. FLORIDA MEDICAL ASSOCIATION INC 1430 PIEDMONT DR TALLAHASSEE: FL 32308 59?0559672 TRADE AS 30,000. 0. FLORIDA ROUNDTAELE 2640 A MITCHAM DR TALLAHASSEE, FL 32308 46?4020904 527 POLITICAL OR 12,500. 0. FORDS THEATRE SOCIETY 514 10TH STREET NW WASHINGTON, DC 20004 52?6073157 CHARITAB 25,000. . 432241 05-01?14 IL45 Schedule (Form 990) PHARMACEUTICAL RESEARCH MANUFACTURERS Schedule I (Form 990} OF AMERICA Page 1 I Part Ill Continuation of Grants and Other Assistance to Governments and Organizations in the United States {Schedule I {Form 990). Part II.) Name and address of organization or government EIN {cl IRC section if applicable Amount of cash grant Amount of non-cash assistance Method of valuation (book, FMV. appraisal, other) (9) Description of non-cash assistance Purpose of grant or assistance FOUNDATION FOR CHILDREN INC 104 HUNGERFORD ST HARTFORD, CT 05106 06?1392883 CHARITAE 152,000. FONTRIB-GENERAL FOUNDATION FOR THE NATIONAL INSTITUTE OF HEALTH 9650 ROCKVILLE PIKE BETHESDA, MD 20814 52?1985675 CHARITAB 300,000. CONTRIB-GENERAL FRANKLIN CENTER FOR GLOBAL POLICY EXCHANGE - 1155 15TH ST NW SUITE 550 WASHINGTON, DC 20005 52?1159816 CHARITAB 25,000. FRENCH AMERICAN CULTURAL FOUNDATION 4101 RESERVOIR ROAD NW WASHINGTONI DC 20007 52~2109476 CHARITAE 10,000. CONTRIB-EVENT GENERAL FRIENDS OF CANCER RESEARCH 1800 STREET NW STE 1050 TOWER WASHINGTON, DC 20036 52?1983273 CHARITAB 100,000. FRIENDS OF MICHAEL MADIGAN PO BOX 3188 CHICAGO: IL 60654 36?3418024 527 POLITICAL OR 12,000. GALEN INSTITUTE INC PO BOX 320010 VA 22320 54?1770524 CHARITAB 60,000. GALIEN FOUNDATION 60 BROAD ST STE 3502 KVB NEW YORK, NY 10004 26?4549935 CHARITAB 50,000. GAY LESBIAN MEDICAL ASSOCIATION 1325 18TH STREET SUITE 22 DC 20036 94?2901694 CHARITAB 10,000, GENERAL 432241 05-01-14 1416 Schedule (Farm 990) PHARMACEUTICAL RESEARCH MANUFACTURERS Schedule I {form 990) OF AMERICA 53?0 241211 Paqe1 I Part ill Continuation of Grants and Other Assistance to Governments and Organizations in the United States {Schedule {Form 990}, Part II.) Name and address of EIN IRC section (cl) Amount of Amount of Method of (9) Description of Purpose of grant organization or government if applicable cash grant non-cash valuation non-cash assistance or assistance assistance (book, FMV, appraisal, other) GAY LESBIAN VICTORY INSTITUTE 1133 15TH ST NW STE 350 WASHINGTON, DC 20005 52?1835268 CHARITAB 15,000, 0. CONTRIE-GENERAL GENETIC ALLIANCE 4301 CONNECTICUT AVE NW SUITE 404 WASHINGTON, DC 20008 52?1571905 CHARITAB 329,296. 0. GEORGE MASON UNIVERSITY FDN LAW ECONOMICS CTR - 3301 FAIRFAX DRIVE - VA 22201 54?1603842 CHARITAB 75,000. 0. CONTRIB-EVENT GENERAL GERMAN MARSHALL FUND OF THE UNITED STATES 1744 STREET NW WASHINGTON, DC 20009 52?0954751 CHARITAB 200,000, 0. GLOBAL COLON CANCER ASSOCIATION 333 EAST CITY AVE STE PL 14 BALA PA 19004 46?0657002 CHARITAB 20,000, 0. CONTRIB-GENERAL GLOBAL VIRUS NETWORK INC 801 BALTIMORE ST STE 519 BALTIMORE, MD 21201 45-2734306 CHARITAB 10,000, 0. GOVERNORS CUP FOUNDATION INC 755 RIVERPOINT DR WEST SACRAMENTO, CA 95505 50-0355309 CHARITAB 30'000, 0. CONTRIB-EVENT GENERAL GREATER DES MOINES PARTNERSHIP 700 LOCUST STREET STE 100 DES MOINES, IA 50309 42?1489658 TRADE AS 15,000. 0. CONTRIB-EVENT GENERAL GROWING FLORIDAS FUTURE 610 BLVD TAMPA, FL 33606 45-3841426 527 POLITICAL OR 20,000. 0. CONTRIE-POLITICAL Schedule I (Form 990) 432241 05-01?14 147 PHARMACEUTICAL RESEARCH MANUFACTURERS Schedule I lForm 990) OF AMERICA 53?0241211 Paqel I Part II I Continuation of Grants and Other Assistance to Governments and Organizations in the United States (Schedule {Form 990}. Part II.) Name and address of EIN IRC section Amount of Amount of Method of (9) Description of Purpose of grant organization or government if applicable cash grant non-cash valuation non-cash assistance or assistance assistance (book. FMV, appraisal, other) HARVARD MEDICAL SCHOOL 130 LONGWOOD AVE BOSTONII MA 02115 04?2103580 CHARITAB 335,000. 0. CONTRIB-GENERAL HEALTH HIV 2000 STREET NW DC 20009 52?2253960 CHARITAB 25,000. 0. HEALTHCARE LEADERSHIP COUNCIL 750 9TH ST NW STE 500 WASHINGTON. DC 20001 36?3668803 TRADE AS 425,000, 0. CONTRIB-GENBRAL HEP CONNECTION 1325 COLORADO BLVD STE 3302 DENVER: CO 80222 31?1525211 CHARITAB 35,000. 0. HISPANIC FEDERATION INC 55 EXCHANGE PLACE STE 501 NEW NY 10005 13?3573852 CHARITAE 12,500. 0. GENERAL HISPANIC HERITAGE FOUNDATION 9575 MAIN ST STE FAIRFAX. VA 22031 52?1818255 CHARITAB 10.000, 0. CONTRIB-GENERAL CENTER STAGE LLC 233 AVE SE 2ND FL WASHINGTON, Dc 20003 26?1582012 LLC 10,000, 0. GENERAL HOGAN RUTHERFORD INAUGURAL COMMITTEE INC 2702 LIGHTHOUSE POINT EAST STE 625 BALTIMORE, MD 21224 47?2395313 527 POLITICAL OR 10,000, 0. HOPE FOR THE WARRIORS 1335 WESTERN BLVD STE ENE 48 JACKSONVILLE. NC 23545?5539 20?5132295 501(c)3 CHARITAB 10,000. 0. CONTRIB-GENERRL Schedule (Form 990) 432241 05?01-14 148 PHARMACEUTICAL RESEARCH MANUFACTURERS OF AMERICA Scheduie {Form 990} 53'0241211 P?ei Part Continuation of Grants and Other Assistance to Governments and Organizations in the United States {Schedule {Form 990), Part II.) Name and address of organization or government EIN IRC section if applicable Amount of cash grant (9) Description of non-cash assistance Purpose of grant or assistance Amount of non-cash assistance Method Of valuation (book1 appraisal, other) INSTITUTE FOR POLICY INNOVATION 1320 GREENWAY DRIVE STE 820 IRVING, Tx 75038 75?2158093 CHARITAB 35,000. 0. INTEGRATED LEGISLATIVE STRATEGIES LLC 701 8TH ST NW STE 520 WASHINGTONI DC 20001 57?1184710 LLC 7,500. 0. CONTRIBHGENERAL INTERNATIONAL FOUNDATION FOR AUTOIMMUNE ARTHRITIS 4055 138TH STREET UNIT HAWTHORNE, CA 90250 27-1214308 CHARITAB 5,000. 0 INTERNATIONAL SOC FOR PHARMACOECONOMICS 505 LAWRENCE SQUARE BLVD SOUTH LAWRENCEVILLE, NJ 03548 22?3369741 CHARITAE 45,000. 0. GENERAL IOWA BIOTECHNOLOGY ASSOCIATION 900 DES MOINES ST DES IA 50309 39?1885797 TRADE AS 9,500. 0. CONTRIB-GENERAL JDRF INTERNATIONAL 26 BROADWAY 15TH FLOOR NEW YORK, NY 10004 23?1907729 CHARITAB 67,500. 0. CONTRIB-GENERAL JEFFERSON AWARDS FOR PUBLIC SERVICE 100 10TH ST STE 215 WILMINGTON, DE 19801 52?0959336 CHARITAB 50,000. D. JOBS FOR AMERICAS GRADUATE INC 1729 KING STREET SUITE 100 ALEXANDRIA, VA 22314 52?1194546 CHARITAB 30,000. 0. JOBS PAC PO BOX 12945 SALEM, OR 97309 46?3517286 527 POLITICAL OR 70,000. 0 432241 05-01?14 1550 Schedule I (Form 990) PHARMACEUTICAL RESEARCH 25: MANUFACTURERS Schedue I {Form 990} OF AMERICA 53?0241211 Paqe1 Part II Continuation of Grants and Other Assistance to Governments and Organizations in the United States (Schedule! {Form 990}. Part II.) Name and address of EIN IRC section Amount of Amount of Method of (9) Description of Purpose of grant organization or government if applicable cash grant non-cash valuation non-cash assistance or assistance assistance (book, FMV, appraisal, other) HOUSE REPUBLICAN CAMPAIGN COMMITTEE INC PO BOX 71596 VA 23255 20?1834893 CORPORATION 7,500. 0. HUDSON INSTITUTE 1015 15TH ST NW STE 600 WASHINGTONI DC 20005 13?1945157 CHARITAE 300,000. 0. GENERAL HUMAN RIGHTS CAMPAIGN FOUNDATION 1640 RHODE ISLAND AVE NW WASHINGTON. DC 20036 52?1431896 CHARITAB 25_000. IBIO INSTITUTE 65 WACKER PLACE SUITE 1600 CHICAGO, IL 60601 32?0092551 CHARITAB 12,500, 0. IDAHO GOVERNORS CUP PO BOX 983 BOISE, ID 83701 20?8277115 CHARITAB 12,000. 0. CONTRIB-EVENT GENERAL ILLINOIS INAUGURATION 2015 NFP 400 NORTH MICHIGAN AVE STE S450 CHICAGO. IL 60611 47?2258590 MEMBERSH 10,000. D, INDEPENDENT VOTER PROJECT 101 WEST BROADWAY STE 1460 SAN DIEGO, CA 92101 20?4842091 MEMBERSH 15,000, D, CONTRIB-GENERAL INFORMA BUSINESS INFORMATION INC PO BOX 417323 MA 02241?7323 04?2705709 CORPORATION 15,000, 0. CONTRIB-GENERAL INFORMATION TECHNOLOGY INNOVATION FOUNDATION 1101 ST STE 610 DC 20005 20?4403497 501(c)3 CHARITAB 102,500. 0. GENERAL Schedule I (Form 990) 432241 05-01-14 149 PHARMACEUTICAL RESEARCH 8: MANUFACTURERS Schedule {Form 990} OF AMERICA 5 3-0 241211 Paqel 1 Part II I Continuation of Grants and Other Assistance to Governments and Organizations in the United States (Schedulel {Form 990). Part ll.) Name and address of EIN IRC section Amount of Amount of Method of (9) Description of Purpose of grant organization or if applicable cash grant non-cash valuation non-cash assistance or assistance assistance (book, FMV, appraisal, other) JOHNS HOPKINS UNIVERSITY 615 WOLFE STREET ROOM E2132 BALTIMORE. MD 21205 52-0595110 CHARITAB 251000, 0. KENTUCKY LIFE SCIENCES COUNCIL 3005 WHITEWAY AVE LOUISVILLE, KY 40205 45?4864224 TRADE AS 25,000, 0. CONTRIB-GENERAL KEYSTONE CENTER 1528 SAINTS JOHN ROAD CO 80435 84?0588506 CHARITAB 10,000. 0. GENERAL KILLEEREW THOMPSON MEMORIAL FUND PO BOX 232 ID 83353 82?0341683 CHARITAB 10,000. 0, CONTRIB-GENERAL KNOCK OUT ABUSE AGAINST WOMEN 1050 17TH STREET NW STE 1200 WASHINGTON. DC 20035 54-1907723 CHARITAB 10,000. 0. GENERAL A REPUBLICAN LEGISLATIVE DELEGATION PO BOX 44422 BATON ROUGE, LA 70804?4422 72?1259311 527 POLITICAL OR 6_000. 0, LAB SCHOOL OF WASHINGTON 4759 RESERVOIR ROAD NW WASHINGTON, DC 20007 52-1261627 CHARITAB 7,500. 0. CONTRIB-GENERAL LATINO COMMISSION ON AIDS 24 25TH ST 9TH FLOOR NEW YORKI NY 10010 13?3629456 CHARITAB 6,000_ 0_ CONTRIB-GENERAL LEADERSHIP COUNCIL PO BOX 11025 WA 98508 91?1714850 527 POLITICAL OR 10,000. 0, CONTRIB-POLITICAL Schedule I (Form 990) 432241 05-01-14 151 PHARMACEUTICAL RESEARCH 8c MANUFACTURERS Schedue I [Form 990} OF AMERICA 53- 0241211 Paqe1 I Part II Continuation of Grants and Other Assistance to Governments and Organizations in the United States {Schedule I {Form 990]. Part II.) Name and address of EIN IRC section Amount of Amount Of Method of (9) Description of Purpose of grant organization or government if applicable cash grant non-cash valuation non-cash assistance or assistance assistance (book. FMV. appraisal. other) LEAGUE OF UNITED LATIN AMERICAN CITIZENS - 201 MAIN STE 505 EL PASO: TX 79901 74-6090399 CHARITAB 10,000, 0. GENERAL LEUKEMIA SOCIETY 5811 SHAWNEE MISSION PKWY STE 202 SHAWNEE MISSION, KS 56202 13?5644915 CHARITAE 123,900. 0. CONTRIB-GENERAL LIABILITY REFORM COALITION 2001 6TH AVE STE 2700 WA 98121 91?1504205 TRADE AS 10_000, 0, LUNGEVITY FOUNDATION 5917 ARLINGTON RD STE 352 MD 20814 36?4433410 CHARITAB 10,000. 0. CONTRIB-EVENT GENERAL LUPUS FOUNDATION OF AMERICA 1319 ST NW STE 305 DC 20004 23-7448063 CHARITAB 11,500. 0. CONTRIB-GENERAL LUPUS FOUNDATION OF AMERICA INC 2000 ST NW STE 410 WASHINGTONJ DC 20036 43?1131436 CHARITAE 50,000. 0. GENERAL LUPUS FOUNDATION OF MID AND NORTHERN NEW YORK INC 5279 TILDEN HILL RD NY 13478 16?1083229 501(c)3 CHARITAB 11,000. 0. MAGNUM ENTERTAINMENT GROUP 601 13TH ST Nw STE 1100 WASHINGTON, DC 20005 02?0699198 CORPORATION 10,000. 0. MAINE SENATE REPUBLICAN MAJORITY PAC PO BOX 1 AUGUSTA, ME 04332 26?3733192 POLITICAL COMMIT 8,000. 0. Schedule I (Form 990) 432241 05?01-14 152 PHARMACEUTICAL RESEARCH MANUFACTURERS OF AMERICA Schedule i i Form 990') Paqei i Part Continuation of Grants and Other Assistance to Governments and Organizations in the United States {Schedule 1 (Form 990}. Part ii.) Name and address of organization or government EIN section if applicable Amount of cash grant (2) Amount of non-cash assistance Method of valuation (book, FMV, appraisal, other) (9) Description of non-cash assistance Purpose of grant or assistance MANHATTAN INSTITUTE FOR POLICY RESEARCH 52 VANDERBILT AVENUE - NEW NY 10017 13-2912529 CHARITAB 30,000. 0. CONTRIB-GENERAL MARCH OF DIMES FOUNDATION 500 WINDING BROOK DRIVE SUITE 8 GLASTONBURY. CT 06033 13?1846366 CHARITAB 27,600. 0. CONTRIE-GENERAL MARQUETTE UNIVERSITY 1250 WEST WISCONSIN AVE WI 53045 39?0806251 CHARITAB 5.060. O, MASSACHUSETTS LATINO CHAMBER OF COMMERCE 1655 MAIN ST MA 01103 04?2774010 CHARITAE 7,500. 0. CONTRIE-GENERAL MASSACHUSETTS TAXPAYERS FOUNDATION 333 WASHINGTON ST STE 853 BOSTON, MA 02108 04?1590310 CHARITAB 10,000. 0. CONTRIB-GENERAL MEDCHI MARYLAND STATE MEDICAL SOCIETY - 1211 CATHEDRAL ST MD 21201 52?0410730 TRADE AS 78,500. 0. MELANOMA RESEARCH ALLIANCE 1101 NEW YORK AVE NW STE 620 DC 20005 25?1635099 CHARITAB 10,000. 0. CONTEIE-GENERAL MENTAL HEALTH AMERICA OF INDIANA 1431 DELAWARE ST INDIANAPOLIS, IN 45202 35?0896905 CHARITAB 6,500. 0 MICHBIO PO BOX 130199 ANN ARBOR. MI 48113?0199 38?3142021 TRADE AS 18,500, 0. 432241 05-01-14 1553 Schedule (Form 990) PHARMACEUTICAL RESEARCH MANUFACTURERS Schedule i [Form 990] OF AMERICA 5 3 - 0 2 4.12 1 Page-1 I Part II I Continuation of Grants and Other Assistance to Governments and Organizations in the United States (Schedule! [Form 990}. Part II.) Name and address of EIN section Amount of Amount of (fl Method of (9) Description of Purpose of grant organization or government if applicable cash grant non-cash valuation non-cash assistance or assistance assistance (book, FMV, appraisal. other) MICHIGAN REPUBLICAN PARTY ADMINISTRATIVE ACCOUNT 520 SEYMOUR ST - LANSING4 MI 48933 33-1221132 527 POLITICAL OR 621,500, 0. CONTRIB-POLITICAL MIDWESTERN LEGISLATIVE CONFERENCE 701 EAST 22ND ST STE 110 LOMEARD, IL 60148 35-6000818 CHARITAB 15,000, 0. GENERAL MINNESOTA ALLIANCE FOR PATIENT SAFETY - 1300 GODWARD ST NE SUITE 2500 - MINNEAPOLIS. MN 55413 45?4173347 CHARITAB 10,000. D. CONTRIB-GENERAL MOLLYS FUND FIGHTING LUPUS 10117 SE SUNNYSIDE RD STE F408 CLACKAMAS, OR 97015 26~11777l7 501(c)3 CHARITAB 10,000. 0. CONTRIB-GENERAL NAACP ATTN ACCOUNTS RECEIVABLE 4305 MT HOPE DR BALTIMORE, MD 21215 13-1084135 CHARITAB 35,000, 0. CONTRIB-GENERAL NALEO EDUCATIONAL FUND 1122 WASHINGTON BLVD 3RD FLR LOS CA 90015 52-1212849 CHARITAE 40,000. 0. CONTRIB-EVENT GENERAL NAMD 8131 OAK ST SUITE 300 NEW ORLEANSI LA 70118 27?3258188 CHARITAB 15,000. 0. GENERAL NAMI 3803 NORTH FAIRFAX DRIVE #100 VA 22203 43?1201653 CHARITAB 80,000. 0. GENERAL NAMI MARYLAND 10630 LITTLE PATUXENT PKWY STE 475 COLUMBIA. MD 21044 52~1295484 CHARITAB 7,500, 0. CONTRIB-GENERAL Schedule I (Form 990) 432241 05-01-14 154 PHARMACEUTICAL RESEARCH 5c MANUFACTURERS Schedule I [Form 999} OF AMERICA 53-0241211 I Part Continuation of Grants and Other Assistance to Governments and Organizations in the United States {Schedule I (Farm 990}. Part ll.) Name and address of EIN section Amount of Amount of Method of (9) Description of Purpose of grant organization or government if applicable cash grant non-cash valuation non-cash assistance or assistance assistance (book, FMV, appraisal. other) NATIONAL ACADEMY OF SCIENCES INSTITUTE OF MEDICINE 500 5TH ST NW KECK 830 DC 20001 53-0196932 CHARITAB 25,000. 0. NATIONAL ALLIANCE FOR CAREGIVING 4720 MONTGOMERY LANE STE 205 MD 20814 52?1931357 CHARITAE 10,000, 0. NATIONAL ASSN OF STATE BUDGET OFFICERS 444 NORTH CAPITOL ST NW STE 642 WASHINGTON, DC 20001 52?1625594 501(c)3 CHARITAB 20,000. D. NATIONAL ASSOCIATION OF AREA AGENCIES ON AGING INC - 1730 RHODE ISLAND AVE NW STE 1200 WASHINGTON, DC 20035 52?1052345 CHARITAB 10.000. 0. GENERAL NATIONAL ASSOCIATION OF HISPANIC NURSES 6301 RANCH DRIVE AR 72223 91?1010677 CHARITAB 10,000. 0. CONTRIB-GENERAL NATIONAL BLACK CAUCUS OF STATE LEGISLATORS 444 NORTH CAPITOL ST NW STE 622 WASHINGTON, DC 20001 52-1213832 CHARITAB 20,000? 0, CONTRIB-EVENT GENERAL NATIONAL BLACK NURSES ASSOCIATION INC - 8630 FENTON STREET STE 330 SILVER MD 20910 23?7194995 CHARITAB 15,000, 0, GENERAL NATIONAL BUREAU OF ASIAN RESEARCH 1414 NE 42ND STREET STE 300 SEATTLEI WA 98105 91?1444105 CHARITAE 300,000. 0. NATIONAL COALITION FOR CANCER SURVIVORSHIP 1010 WAYNE AVE STE 315 SILVER MD 20910 35#0357897 CHARITAB 20,000. 0. CONTRIB-EVENT GENERAL Schedule I (Form 990) 432241 05-01-14 155 PHARMACEUTICAL RESEARCH MANUFACTURERS SummM Emm9Hn OF AMERICA 53-0241211 P391 I Part Continuation of Grants and Other Assistance to Governments and Organizations in the United States (Schedule I {Form 990}, Part II.) Name and address of EIN section (11) Amount of Amount of Method of (9) Description of Purpose of grant organization or government if applicable cash grant non-cash valuation non-cash assistance or assistance assistance (book, FMV, appraisal, other) NATIONAL CONSUMERS LEAGUE PO BOX 759339 BALTIMORE, MD 21275-9339 53?0242038 501(c)3 CHARITAE 250,000. 0. NATIONAL COUNCIL OF LA RAZA PO BOX 748425 LOS CA 90074?8425 86?0212873 CHARITAB 10,000. 0, CONTRIB-EVENT GENERAL NATIONAL DEMOCRATIC CLUB 30 IVY STREET SE WASHINGTON. DC 20003 53?0233594 SOCIAL l4f500. U, GENERAL NATIONAL FOUNDATION FOR CANCERRESEARCH 3500 MANOR ROAD CHEVY MD 20815 04?2531031 CHARITAB 6.000, 0. NATIONAL FOUNDATION FOR WOMEN LEGISLATORS 1727 KING STREET STE 300 ALEXANDRIA, VA 22314 52?1480735 CHARITAB 15,000. 0. GENERAL NATIONAL HEALTH COUNCIL 1730 STREET NW STE 500 WASHINGTON, DC 20036?4561 13?1624107 CHARITAB 1,183,100. 0. CONTRIB-GENERAL NATIONAL HISPANIC COUNCIL ON AGING 734 15TH NW SUITE 1050 WASHINGTON, DC 20005 52-1305347 CHARITAB 30,000. 0. CONTRIB-GENERAL NATIONAL HISPANIC MEDICAL ASSOCIATION 1920 STREET STE 725 WASHINGTON, DC 20035 52-1884446 TRADE AS 20.000. 0, GENERAL NATIONAL ITALIAN AMERICAN FOUNDATION 1860 19TH ST Nw - WASHINGTON. DC 20009 52?1071723 501(c)3 CHARITAB 10,000. 0, GENERAL Schedule I (Form 990) 432241 05-01-14 2156 PHARMACEUTICAL RESEARCH 8c MANUFACTURERS Schedule I [Form 990] OF AMERICA 5 3?0 241211 Page'l I Part Continuation of Grants and Other Assistance to Governments and Organizations in the United States (Schedule {Form 99% Part II.) Name and address of EIN IRC section Amount of Amount of Method of (9) Description of Purpose of grant organization or government if applicable cash grant non-cash valuation non-cash assistance or assistance assistance (book, FMV, appraisal, other) NATIONAL KIDNEY FOUNDATION 5335 WISCONSIN AVE NW STE 300 DC 20015 13?1673104 CHARITAB 18,500. 0. CONTRIE-GENERAL NATIONAL LIEUTENANT GOVERNORS ASSOCIATION 71 CAVALIER BLVD STE 223 - KY 41042 61-1227811 CHARITAB 50,000. 0. CONTRIB-GENERAL NATIONAL MEDICAL ASSOCIATION 8403 COLESVILLE ROAD STE 820 SILVER SPRING, MD 20910?6331 53?6010805 CHARITAB 19,500. 0. CONTRIB-EVENT GENERAL NATIONAL MINORITY QUALITY FORUM INC 1101 STREET NW STE 350 WASHINGTON. DC 20005 31?1750942 CHARITAB 442,000. 0_ GENERAL NATIONAL MS SOCIETY 1800 STREET NW STE 750 WASHINGTON, DC 20036 53-0237585 CHARITAB 13,000. 0. GENERAL NATIONAL MULTIPLE SCLEROSIS SOCIETY 900 BROADWAY STE 250 CO 80209 84?0412595 CHARITAB 10,000. 0. NATIONAL OSTEOPOROSIS FOUNDATION 1150 17TH ST STE 850 WASHINGTON. DC 20035 36?3350532 CHARITAB 10,000. 0. CONTRIB-GENERAL NATIONAL PARTNERSHIP FOR FAMILIES 1875 CONN AVE NW STE 650 WASHINGTON, DC 20009 23?7124915 CHARITAE 210,000. 0. GENERAL NATIONAL PRESS FOUNDATION 1211 CONNECTICUT AVE NW STE 310 DC 20036 52?1069481 CHARITAB 7,000, 0. CONTRIS-GENERAL Schedule I (Form 990) 432241 05-01-14 157 PHARMACEUTICAL RESEARCH MANUFACTURERS Schedule I [Form 99D) OF AMERICA 53-0241211 Paqet I Part Continuation of Grants and Other Assistance to Governments and Organizations in the United States {Schedule I {Form 990]. Part II.) Name and address of EIN lFiC section Amount of Amount of Method of (9) Description of Purpose of grant organization or government if applicable cash grant non-cash valuation non-cash assistance or assistance assistance (book. FMV, appraisal, other) NATIONAL QUALITY FORUM 1030 FIFTEENTH STREET N.W. DC 20005 52?2175544 CHARITAB 28,350. 0. NATL ASSN OF NUTRITION AGING SERVICES PROGRAMS - 1512 ST STE 400 DC 20006 04?2639088 CHARITAB 65,000, 0, FONTRIB-GENERAL NATL COUNCIL OF ASIAN PACIFIC ISLANDER PHYS 445 GRANT AVENUE STE 202 SAN FRANCISCO, CA 94108 27?3429376 CHARITAB 10,000. 0. NATL GOVERNORS ASSN CTR FOR BEST PRACTICES 444 NORTH CAPITOL ST NW STE 267 WASHINGTON, DC 20001?1512 23?7391796 CHARITAB 75,000. 0. GENERAL NCQA DEPT 4038 WASHINGTON, DC 20042 52?1191985 CHARITAB 25,000. 0, CONTHIE-GENERAL NCSL FOUNDATION OF STATE LEGISLATURES 7700 EAST FIRST PLACE DENVER, CO 80230 74?2232576 CHARITAB 25,000. 0. CONTRIESGENERAL NEVADA STATE DEMOCRATIC PARTY 1210 VALLEY VIEW SUITE 114 LAS VEGAS, NV 89102 88?0189294 527 POLITICAL OR 50,000. 0. NEW ENGLAND HEALTHCARE INSTITUTE ONE BROADWAY 15TH FL MA 02142 01?0624855 CHARITAB 120,000, 0. NEW NEVADA PAC Po BOX 370672 LAS VEGAS, Nv 89137 27?3894241 527 POLITICAL 0R 20,000. 0. CONTRIH-POLITICAL Schedule I (Form 990) 432241 05-01-14 IL58 PHARMACEUTICAL RESEARCH MANUFACTURERS Schedule (Form 990] OF AMERICA 53-0241211 Fag? I Part Continuation of Grants and Other Assistance to Governments and Organizations in the United States (Schedule {Form 990). Part II.) Name and address of EIN IRC section Amount of Amount of Method of (9) Description of Purpose of grant organization or government if applicable cash grant non-cash valuation non-cash assistance or assistance assistance (book, appraisal, other) NJ CIVIL JUSTICE REFORM INSTITUTE INC 112 WEST STATE STREET NJ 08508 74?3204389 TRADE AS 30'000, 0. CONTRIB-GENERAL NJ SENATE DEMOCRATIC MAJORITY PO BOX 2890 NJ 08590 90?0039921 527 POLITICAL OR 8,000. 0. CONTRIB-POLITICAL NO STOMACH FOR CANCER INC PO BOX 45070 MADISON, WI 53744 27-1011353 CHARITAB 10'000. 0, CONTRIB-GENERAL NORTHEAST KIDNEY FOUNDATION 501 NEW KARNER ROAD SUITE 5 NY 12205 14?1559082 CHARITAB 6,000? 0. OAKLAND MILITARY INSTITUTE 3877 LUSK STREET OAKLAND. CA 94608 91?2073068 CHARITAB 10,000. 0. CONTRIE-EVENT GENERAL OLD NORTH STATE MEDICAL SOCIETY 114 WEST PARISH ST STE 300 DURHAM, NC 27701 56?6060861 CHARITAB l3_000_ 0. GENERAL ONE STATE ONE FUTURE POB 17598 NO 47887 BALTIMORE, MD 21297-1598 46-3374309 527 POLITICAL 0R 25,000. 0. OREGON REAGAN 2014 PAC 22380 RICKARD ROAD BEND, OR 97702 45-5434287 527 POLITICAL OR 15,000, 0, OVARIAN CANCER NATIONAL ALLIANCE 1101 14TH ST NW STE 850 WASHINGTON, DC 20005 31-1581756 CHARITAB 20,000. 0, GENERAL Schedule I (Form 990) 432241 05?01-14 159 PHARMACEUTICAL RESEARCH S: MANUFACTURERS Schedule I [Form sen) OF AMERICA 53-0241211 Fag? Part II I Continuation of Grants and Other Assistance to Governments and Organizations in the United States {Schedule I {Form 990}. Part II.) Name and address of EIN IRC section Amount of Amount of Method of (9) Description of Purpose of grant organization or government if applicable cash grant non-cash valuation non-cash assistance or assistance assistance (book, FMV, appraisal, other) PACIFIC RESEARCH INSTITUTE 1 EMBARCADERO CENTER STE 350 SAN FRANCISCO, CA 94111 94-2528433 CHARITAB 55,000. 0. CONTRIE-GENERAL PANCREATIC CANCER ACTION NETWORK 1500 ROSECRANS AVENUE STE 200 MANHATTAN BEACHI CA 90266 33?0841281 CHARITAB 11,770. 0. NTRIE-GENERAL PARKINSON ACTION NETWORK 1025 VERMONT AVE NW STE 1120 WASHINGTON, DC 20005 94?3172675 CHARITAB 15'000, 0. CONTRIB-GENERAL PARTNERSHIP FOR DRUG FREE KIDS 352 PARK AVE SOUTH 9TH FL NEW YORK, NY 10010 13?3413627 CHARITAB 250,000. 0. PATIENT ADVOCATE FOUNDATION 421 BUTLER FARM RD VA 23666 54?1805317 CHARITAB 25,000. 0. BIOTECHNOLOGY ASSOCIATION 650 SWEDESFORD RD STE 190 WAYNE, PA 19087 25?1621500 TRADE AS 20,000. 0_ CONTRIB-GENERAL PHRMA COLORADO ACTION FUND 1740 BROADWAY DENVER, CO 80274 20-5123531 527 POLITICAL OR 100,000. a. PHRMA FOUNDATION 950 STREET NW STE 300 WASHINGTONI DC 20036 52-6063009 CHARITAB 500,000. 0, PHRMA INDEPENDENT EXPENDITURE COMMITTEE 1127 11TH ST SUITE 300 SACRAMENTO, CA 95814 90?0239652 POLITICAL COMMIT 507,998, 0, Schedule I (Form 990) 432241 05-01-14 160 PHARMACEUTICAL RESEARCH Sc MANUFACTURERS Schedule {Form SE OF AMERICA 53_ [)241211 Paqe1 I Part II I Continuation of Grants and Other Assistance to Governments and Organizations in the United States {Schedulel [Form 99D), Part ll.) Name and address Of section Amount of Amount Of Method of Description of Purpose of grant organization or government if applicable cash grant non-cash valuation non-cash assistance or assistance assistance (book, FMV, appraisal, other) PHRMA PAC 1127 11TH ST SUITE 300 SACRAMENTO. CA 95814 20?4447742 POLITICAL COMMIT 116,000. 0. PHRMA TENNESSEE POLITICAL ACTION COMMITT - 100 GALLERIA PKWY STE 1130 - ATLANTA, GA 30339 35?4746919 527 POLITICAL OR 10,000. 0. CONTRIB-POLITICAL PHYSICIAN ASSISTANT FOUNDATION 2318 MILL ROAD STE 1300 VA 22314 54?1071370 CHARITAB 10,000, 0, PQA 6213 OLD KEENE MILL COURT VA 22152 26?2968498 501(c)3 CHARITAB 40,000. 0. GENERAL PRES DIR OF GEORGETOWN COLL FOR GEORGETOWN UNIV 3300 WHITEHAVEN ST NW STE 4000 WASHINGTON, DC 20007 53?1096603 501(c)3 CHARITAB 362,559. 0. CONTEIB-GENERAL PRESCRIPTION DRUG ASSISTANCE FOUNDATION 1111 HARVARD AVE SEATTLE: WA 98104 33?1134368 CHARITAB 15.000, 0. PREVENT CANCER FOUNDATION 1600 DUKE STREET STE 500 ALEXANDRIAII VA 22314 52-1429544 CHARITAB 25,000. 0. GENERAL PROJECT HOPE PEOPLE TO PEOPLE HEALTH FDN INC A 7500 OLD GEORGETOWN ROAD STE 500 MD 20814?5133 53?0242962 CHARITAB 1011250, U. REGULATORY AFFAIRS PROFESSIONALS SOCIETY 5635 FISHERS LANE STE 550 - ROCKVILLE, MD 20852 52-1139030 CHARITAB 35,000. D. Schedule I (Form 990) 432241 05-01-14 1(51 PHARMACEUTICAL RESEARCH Sc MANUFACTURERS Schedu {Form 390} OF AMERICA 5 3-0241211 Page"! Part II Continuation of Grants and Other Assistance to Governments and Organizations in the United States {Schedule I {Form 990). Part II.) Name and address Of EIN lFiC section Amount of Amount of Method of (9) Description of Purpose of grant organization or government if applicable cash grant non-cash valuation non-cash assistance or assistance assistance (book, FMV, appraisal, other) REPUBLICAN ASSEMBLY CAMPAIGN COMMITTEE - 315 STATE STREET - NY 12210 14?1713936 POLITICAL COMMIT 25,500. 0. REPUBLICAN ATTORNEYS GENERAL ASSOCIATION 1747 AVE NW STE 800 WASHINGTON, DC 20006 45~4501717 527 POLITICAL OR 50,000. 0. REPUBLICAN GOVERNORS ASSOCIATION 1747 AVE NW STE 250 WASHINGTON, DC 20006 11?3655877 POLITICAL COMMIT 455,000. 0, REPUBLICAN STATE LEADERSHIP COMMITTEE - 1201 ST NW STE 675 DC 20004 05-0532524 527 POLITICAL OR 225,000. 0_ PO BOX 222451 VA 20153?2451 52?1609875 CHARITAB 6,000, 0. CONTRIB-GENERAL RETIRESAFE 1516 ST NW STE 902 WASHINGTON. DC 20006 48?1108059 MEMBERSH 25,000. 0. RX RESPONSE 950 STREET NW STE 300 WASHINGTON. DC 20004 46?3134601 CHARITAB 35.036. 0. CONTRIE-GENERAL SANDRE SWANSON YOUTH FOUNDATION 925 STREET N0 1402 CA 95814 27?4362450 CHARITAE 12,500, 0. CONTRIB-EVENT GENERAL SENATE DEMOCRATIC CAMPAIGN COMMITTEE 111 WASHINGTON AVE STE 409 - ALBANY, NY 12210 01?0478979 POLITICAL COMMIT 56,500. 0, Schedule (Form 990) 432241 05-01-14 162 PHARMACEUTICAL RESEARCH Sc MANUFACTURERS Schedule {Farm 990} OF AMERICA Page ?i Part Ili Continuation of Grants and Other Assistance to Governments and Organizations in the United States (Schedule I (Farm 990). Part ll.) Name and address of EIN IRC section Amount of Amount of Method of Description of Purpose of grant organization or government if applicable cash grant non-cash valuation non-cash assistance or assistance assistance (book. FMV. appraisal, other) SENATE PRESIDENTS FORUM 56 WITHERSPOON STREET STE 226 PRINCETON- NJ 08540 22?3284046 CHARITAB 28,000. 0. CONTRIB-GENERAL SENATE REPUBLICAN CAMPAIGN COMMITTEE 152 WASHINGTON AVE ALBANY, NY 12210 14?1753554 527 POLITICAL OR 88,500. 0. CONTRIB-POLITICAL SOCIETY FOR WOMENS HEALTH RESEARCH 1025 CONNECTICUT AVENUE NW STE 601 WASHINGTONI DC 20036 52?1694732 CHARITAB 40?000. 0. CONTRIB-EVENT GENERAL SOUTH CAROLINA BIOTECHNOLOGY ORGANIZATION (SCBIO) 411 UNIVERSITY RIDGE STE A SC 29601 20?0513951 CHARITAB 10?000, 0. GENERAL STATE LEGISLATIVE LEADERS FOUNDATION 1645 FALMOUTH RD BLDG - MA 02532?2932 23-7148478 CHARITAB 25,000, 0. GENERAL STUDENT NATIONAL MEDICAL ASSOCIATION - 5113 GEORGIA AVE NW DC 20011 52?0965479 CHARITAB 10.000. 0. GENERAL SUSANA MARTINEZ 6100 UPTOWN BLVD STE 590 NM 37110 27?0624912 POLITICAL CANDID 5?200_ 0. CONTRIB-POLITICAL TEXAS CONSERVATIVE COALITION RESEARCH IN - PO BOX 2659 AUSTIN, TX 78768 74-2763191 CHARITAB 27,500. 0. THIRD WAY FOUNDATION 1101 14TH ST NW STE 1250 WASHINGTON. DC 20005 52?1629221 CHARITAB 75,000. 0_ Schedule I (Form 990) 432241 05?0 1? 14 163 PHARMACEUTICAL RESEARCH MANUFACTURERS OF AMERICA Schedule {Form 990} 53-0241211 Pagei I Part I Continuation of Grants and Other Assistance to Governments and Organizations in the United States {Schedule-I [Form 990). Part Name and address of organization or government EIN section if applicable Amount of cash grant Amount Of (9) Description of non-cash assistance Purpose of grant or assistance Method of valuation (book, FMV, appraisal, other) non-cash assistance TOUGALOO COLLEGE 500 WEST COUNTYLINE RD MS 39174 64?0303093 CHARITAE 10,000. 0, COETRIB-GENERAL TUFTS CENTER FOR THE STUDY OF DRUG DEVELOPMENT 75 KNEELAND STREET STE 1100 BOSTON, MA 02111 04-2103634 CHARITAB 204,800. TUFTS MEDICAL CTR EVAL OF VALUE RISK IN HLTH 800 WASHINGTON STREET BOSTON, MA 02111 04?3400617 CHARITAB 10,000. 0. CONTRIB-GENERAL UNITED FOR MEDICAL RESEARCH 1200 NEW YORK AVE NW STE 550 WASHINGTON, DC 20005 52?1947112 CHARITAB 30,000. 0. UNITED SPINAL ASSOCIATION 75 20 ASTORIA BLVD STE 120 EAST ELMHURST, NY 11370-1177 13?5612621 CHARITAB 10,000. 0. US ALGERIA BUSINESS COUNCIL 2001 JEFFERSON DAVIS HWY STE 208 VA 22202 75?3078512 TRADE AS 57,737. 0. US PAIN FOUNDATION INC 570 NEWFIELD STREET SUITE CT 06457 26?2703521 CHARITAB 15,000, 0, USA INDIA CHAMBER OF COMMERCE INC 3 CAPSTAN WAY SWAMPSCOTT, MA 01907 42?1703723 CORPORATION 30,000, 0. CONTRIB-EVENT GENERAL UTAH FAMILIES FOUNDATION 9160 SOUTH 300 WEST 21 SANDY, UT 84070 87?0509416 CHARITAB 40,000. 0 GENERAL 432241 05?0144 1(34 Schedule I (Form 990) PHARMACEUTICAL RESEARCH MANUFACTURERS OF AMERICA Schedule [Fm-m 990) 53?0241211 I Part Continuation of Grants and Other Assistance to Governments and Organizations in the United States [Schedute I (Form 990). Part II.) Page 1 Name and address of organization or government EIN IRC section if applicable Amount of cash grant Amount of non-cash assistance Method of valuation (book. FMV, appraisal, other) (9) Description of non-cash assistance Purpose of grant or assistance VERMONT BIOSCIENCES ALLIANCE PO BOX 2104 SOUTH BURLINGTON, VT 05407?2104 27?0259923 MEMBERSH 15,000. CONTREE-GENERAL VIRGINIA CENTER FOR HEALTH INNOVATION 919 MAIN STREET STE 900 VA 23219 80?0796077 CHARITAB 30,000. CONTRIB-EVENT GENERAL VIRGINIA SENATE REPUBLICAN CAUCUS PO BOX 1697 WILLIAMSBURG, VA 23137 26?2971834 527 POLITICAL OR 7,500. WASHINGTON INTERNATIONAL TRADE FOUNDATION 1300 AVE NW STE 400 DC 20004 52?1907420 CHARITAB 10,200. CONTRIB-EVENT GENERAL WASHINGTON LEGAL FOUNDATION 2009 MASSACHUSETTS AVE NW WASHINGTON, DC 20036 52?1071570 CHARITAB 15,000. CONTRIB-GENERAL WASHINGTON POLICY CENTER PO BOX 3643 SEATTLE, WA 98124?3643 91-1752769 CHARITAB 22,500. CONTRIB-GENERAL WOMEN IN GOVERNMENT FOUNDATION INC 1319 ST NW STE 710 WASHINGTON, DC 20004 54?1527192 CHARITAB 120,000. CONTRIB-EVENT GENERAL WOMENS FOREIGN POLICY GROUP 1515 STREET NW STE 210 WASHINGTON, DC 20036 52?1818839 CHARITAB 8,000. CONTRIB-GENERAL WOODROW WILSON INTL CENTER FOR SCHOLARS 1300 AVE NW WASHINGTON, DC 20004 52?1067541 CHARITAB 60,000. 432241 05-01-14 1(35 Schedule I (Form 990) PHARMACEUTICAL RESEARCH MANUFACTURERS OF AMERICA Continuation of Grants and Other Assistance to Governments and Organizations in the United States {Schedule (Form 990], Part II.) Schedu I (Form 9901 Part II 53?0241211 Page 1 Name and address of organization or government EIN IRC section if applicable Amount of cash grant Amount of non?cash assistance Method of valuation (book, FMV, appraisal. other) (9) Description of non-cash assistance Purpose of grant or assistance WYOMING CONGRESSIONAL AWARD COUNCIL PO BOX 462 WY 82325 83-0264565 CHARITAB 10,000. CONTEIE-EVENT GENERAL XCONOMY INC 215 FIRST STREET STE 030 CAMBRIDGE, MA 02142 02?0807038 CORPORATION 7,000. CONTRIB-GENERAL YELLOW RIBBON FUND INC 4905 DEL RAY AVE STE 500 BETHESDA, MD 20814 36?4567583 CHARITAB 15,000, CONTRIB-EVENT GENERAL YMCA OF SAN JUAN PO BOX 360590 SAN PR 00936 66-0190784 CHARITAB 15,000, CONTRIB-GENERAL YMCA OF WILMINGTON INC 2710 MARKET STREET NC 28403 56~05323l7 CHARITAB 10,000. 432241 05-01-14 1(36 Schedule 1 (Form 990) PHARMACEUTICAL RESEARCH S: MANUFACTURERS Schedule (Form 95g) @014) OF AMERICA Pace 2 I Part I Grants and Other Assistance to Domestic Individuals. Complete if the organization answered "Yes" to Form 990, Part IV, line 22. Part can be duplicated if additional space is needed. Type of grant or assistance Number of Amount of (cl) Amount of non- Method of valuation Description of non-cash assistance recipients cash grant cash assistance (b00k. FMV. appralsal. other) I Part I Supplemental Information. Provide the Information required in Part I. line 2. Part column lb). and any other additional information. PART I, LINE 2: DEPENDING ON THE NATURE AND PURPOSE OF THE GRANT, PHRMA MAY REQUIRE THE RECIPIENT OF A GRANT TO SUBMIT PERIODIC REPORTS OR SIMILAR DOCUMENTATION TO VERIFY THAT THE GRANT IS BEING USED APPROPRIATELY FOR THE INTENDED USE. IN GENERAL, UNLESS THE GRANT IS BEING USED TO SUPPORT A SPECIFIC EFFORT OR PROJECT, THEN NO ADDITIONAL FORMAL MONITORING MAY BE INVOLVED BEYOND ENSURING APPROPRIATE DOCUMENTATION OF THE GRANT AND LEGITIMACY OF THE RECIPIENT ORGANIZATION. IRRESPECTIVE OF THE NATURE OR PURPOSE OF THE GRANT, PHRMA AWARDS GRANTS BASED ON THE UNDERSTANDING THAT RECIPIENTS ARE 432102 10-15-14 Schedule I (Form 990) (2014) 167 PHARMACEUTICAL RESEARCH MANUFACTURERS Schedule I [Em 990} OF AMERICA Page 2 _Part IV Supplemental Information RESPONSIBLE FOR ENSURING THAT GRANTS ARE USED FOR PROPER PURPOSES AND IN COMPLIANCE WITH ALL LEGAL REQUIREMENTS. Scheduhl(Forn 990) 432291 05-01-14 168 12161109 790809 53?0241211 2014.05000 PHARMACEUTICAL RESEARCH 82 53?02411 SCHEDULE Compensation Information ova No 1545-0047 (Form 990) For certain Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees Complete if the organization answered "Yes" on Form 990, Part IV, line 23. Department of the Treasury AttaCh to Form 990- Open to P_Ublic Internal Revanue Service lnformation about Schedule lForm 990] and its instructions is at mggo, Name of the organization PHARMACEUTICAL RESEARCH MANUFACTURERS Employer identification number OF AMERICA 53?0241211 Part I Questions Regarding Compensation Yes No 13 Check the appropriate box(es) if the organization provided any of the following to or for a person listed in Form 990, Part VII, Section A, line 1a. Complete Part to provide any relevant information regarding these items. First-class or charter traVel Housing allowance or residence for personal use Travel for companions Payments for business use of personal residence Tax indemnification and gross-up payments Health or social club dues or initiation fees :1 Discretionary spending account I: Personal services maid, chauffeur, chef) If any of the boxes on line ?la are checked, did the organization follow a written policy regarding payment or reimbursement or provision of all of the expenses described above? If complete Part to explain 1b 2 Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all directors, trustees, and officers, including the CEO/Executive Director, regarding the items checked in line 1a? 2 3 Indicate which, if any, of the following the filing organization used to establish the compensation of the organization's CEO/Executive Director. Check all that apply. Do not check any boxes for methods used by a related organization to establish compensation of the CEO/Executive Director, but explain in Part Compensation committee Written employment contract Independent compensation consultant Compensation survey or study Form 990 of other organizations Approval by the board or compensation committee 4 During the year, did any person listed in Form 990, Part VII, Section A, line 1a, with respect to the filing organization or a related organization: a Receive a severance payment or change-of-control payment? 4a Participate in, or receive payment from, a supplemental nonqualified retirement plan? 4b Participate in, or receive payment from, an equity-based compensation arrangement? 4c If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part Only section 501(c)(3), 501(c)(4). and 501(c)(29) organizations must complete lines 5-9. 5 For persons listed in Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any compensation contingent on the revenues of: a The organization? 5a Any related organization? 5b If "Yes" to line 5a or 5b, describe in Part 6 For persons listed in Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any compensation contingent on the net earnings of: a The organization? Ga Any related organization? 6b If "Yes" to line 6a or 6b, describe in Part 7 For persons listed in Form 990, Part VII, Section A, line 1a, did the organization provide any non-fixed payments not described in lines 5 and 6? If "Yes," describe in Part 7 8 Were any amounts reported in Form 990, Part VII, paid or accrued pursuant to a contract that was subject to the initial contract exception described in Regulations section If "Yes," describe in Part 8 9 If "Yes" to line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section . . 9 LHA For Paperwork Reduction Act Notice, see the Instructions for Form 990. Schedule (Form 990) 2014 432111 10?13?14 169 12161109 790809 53-0241211 2014.05000 PHARMACEUTICAL RESEARCH 53?02411 Schedule (Form 9'90) 2014 PHARMACEUTICAL RESEARCH MANUFACTURERS OF AMERICA 53?0241211 Part ll I Officers. Directors. Trustees. Key Employees. and Highest Compensated Employees. Use duplicate copies if additional space is needed. For each individual whose compensation must be reported in Schedule J, report compensation from the organization on row and from related organizations, described in the instructions, on row 00. Do not list any individuals that are not listed on Form 990, Part VII. Page 2 Note. The sum of columns for each listed individual must equal the total amount of Form 990, Part VII, Section A, line 1a, applicable column (D) and (E) amounts for that individual. (A) Name and Title (B) Breakdown of W-2 and/or 1099-MISC compensation Base compensation (ii) Bonus incentive compensation Other reportable compensation (C) Retirement and other deferred compensation (D) Nontaxable benefits (E) Total of columns (EOE) (F) Compensation in column (B) reported as deferred in prior Form 990 JOHN J. CASTELLANI PRESIDENT CEO (0 an 1,502 ,543. 900,711. 161, 513. 530,895. 23,181. 3,118,843. 447,083ARDELL PERSINGER cs0, EVP (ii) 353 ,405. 142,275. 12, 830. 669,628. 23,610. 1,201,748. 60,975. 58 ,058. O. 0. 0. 58,058. 0. JAMES SPEARS lm 548 ,710. 107,100. 30, 508. 68,003. 29,903. 784,224JEFF BOND SENIOR VP (m 389 ,562. 142,042. 5, 236. 221,576. 21,471. 779,887. 57,816WILLIAM CHIN EVP (m 634 ,541. 343,750. 21, 869. 37,284. 22,753. 1,060,197. 93,750CHARLES CLAPTON SENIOR VP (m 321 .107. 40,000. 2, 224. 22,885. 20,625. 406,841CHESTER DAVIS EVP (m 562 ,308. 197,916. 34, 047. 203,984. 29,618. 1,027,873. 75,416ROSZELL HUNTER SENIOR VP 389 .185. 91,299. 3, 147. 145,286. 26,976. 655,893. 14,034SCOTT LAGANGA SENIOR VP (m 300 ,281. 61,207. 3. 631. 168,449. 22,934. 556,502. 3,156JOSEPHINE MARTIN EVP 401 ,210. 89,517. 3: 200. 146,429. 28,401. 668,757. 21,891LORI REILLY EVP 373 .633. 113,159. 4; I 532. 425,450. 30,961. 947,735. 30,659SALVATORE ALESCI VICE PRESIDENT 327 ,413. 65,280. 4, 057. 26,000. 27,186. 449,936JENNIFER BRYANT VICE PRESIDENT 348 ,804. 94,314. 3, 207. 309,646. 30,156. 786,127. 14,389SANDEEP DHAR VICE PRESIDENT 215 ,420. 90,781. 373, 356. 301,693. 21,012. 1,002,262. 30,685JAY TAYLOR VICE PRESIDENT 343 .284. 99,933. 4.- 506. 190,770. 29,429. 667,922. 31,515IRA WOLF JAPAN REPRESENTATIVE rm 43,978. 84, 464. 162,842. 2,741. 1,064,086432112 10-13-14 170 Schedule (Form 990) 2014 PHARMACEUTICAL RESEARCH MANUFACTURERS ScheduleJ {me 99m 2014 OF AMERICA 5 3?0241211 Page 3 I Part Ill 1 Supplemental Information Provide the information. explanation, or descriptions required for Part I, lines 1aand for Part II. Also complete this part for any additional information. PART I, LINE 1A: FIRST CLASS TRAVEL: THE PRESIDENT IS AUTHORIZED TO TRAVEL USING FIRST CLASS. TRAVEL FOR COMPANIONS: COMPANIONS OCCASIONALLY TRAVEL WITH PHRMA EXECUTIVES ON BUSINESS TRAVEL. IN SUCH CASES, COMPANION TRAVEL IS INCLUDED IN THE TAXABLE INCOME OF THE PHRMA EXECUTIVE. TAX INDEMNIFICATION AND GROSS UP PAYMENTS: THE JAPAN REPRESENTATIVE, AN EXPATRIATE RESIDING IN TOKYO, JAPAN AND ONE OF TOP 5 COMPENSATED EMPLOYEES, IS PAYMENTS MAY BE PROCESSED FOR PHRMA EXECUTIVES WHEN A FRINGE BENEFIT IS CONSIDERED TAXABLE INCOME AND THERE IS A BUSINESS REQUIREMENT GIVING RISE TO THE TAXABLE FRINGE BENEFIT. HOUSING ALLOWANCE: THE APARTMENT LEASE FOR THE JAPAN REPRESENTATIVE WHO RESIDES IN TOKYO, JAPAN, IS PAID FOR BY PHRMA. THE VALUE OF THE APARTMENT LEASE IS INCLUDED IN THE INCOME OF THE JAPAN REPRESENTATIVE AND TAX EQUALIZED. HEALTH OR SOCIAL CLUB DUES: ALL PHRMA EMPLOYEES ARE ELIGIBLE TO PARTICIPATE IN A PHRMA SPONSORED FITNESS CLUB MEMBERSHIP OR MAY RECEIVE A REIMBURSEMENT UP TO A CERTAIN VALUE ANNUALLY FOR A FITNESS CLUB MEMBERSHIP OF THEIR CHOOSING. THE VALUE OF THIS BENEFIT IS CONSIDERED TAXABLE INCOME Schedule (Form 990) 2014 432113 10?13?14 171 PHARMACEUTICAL RESEARCH MANUFACTURERS ScheduleJ [Form 99012014 OF AMERICA 5 3~0241211 =aae a [Lad I Supplemental Information Provide the information, explanation, or descriptions required for Part I, lines 1a, ?Iband for Part II. Also complete this part for any additional information. TO THE EMPLOYEE. THE JAPAN REPRESENTATIVE BELONGS TO THE TOKYO AMERICAN CLUB. THIS CLUB MEMBERSHIP IS PAID FOR BY PHRMA, INCLUDED IN THE INCOME OF THE JAPAN REPRESENTATIVE AND TAX EQUALIZED. PART I, LINES 4A-C: PHRMA SPONSORS A NON-QUALIFIED SECTION DEFERRED COMPENSATION PLAN. AMOUNTS PAID OUT UNDER THIS PLAN ARE INCLUDED IN PART VII (WHEN PAID) AND SCHEDULE J, RESPECTIVELY (WHEN PAID, EARNED AND REPORTED IN A PRIOR YEAR). NAME: 457F (PRIOR YEAR LTIP DEF. COMP PAID IN 2014); 457F (LTIP DEF. COMP AWARDED IN 2014 BUT NOT PAID UNTIL FUTURE YEARS) JEFF BOND: $57,816; $57,086 JOHN CASTELLANI: $447,083; $450,323 WILLIAM CHIN: $93,750; $0 CHESTER DAVIS: $75,416; $100,227 ROSZELL HUNTER: $14,034; $57,949 SCOTT LAGANGA: $3,156; $31,664 JOSEPHINE MARTIN: $21,891; $47,736 Schedule (Form 990) 2014 432113 10-13-14 172 PHARMACEUTICAL RESEARCH MANUFACTURERS Scheduled {Form 99012016. OF AMERICA 53-0241211 Fame 3 Part I Supplemental Information Provide the information, explanation, or descriptions required for Part I, lines 1aand for Part II. Also complete this part for any additional information. ARDELL PERSINGER: $60,975; $0 LORI REILLY: $30,659; $57,500 JAMES SPEARS: $80,325 JENNIFER BRYANT: $14,389; $55,600 SANDEEP DEAR: $30,685: $0 JAY TAYLOR: $31,515; $34,209 OTHER REPORTABLE COMPENSATION SANDEEP DHAR: $332,000 Schedule (Form 990) 2014 432113 10-13-14 173 SCHEDULE Transactions With Interested Persons OMB No; 1545-0047 (Form 990 or 990-EZ) Complete if the organization answered "Yes" on Form 990, Part IV, line 25a, 25b, 26F 27. 28a. 1 4 28b, or 28c, or Form 990-EZ, Part V, line 383 or 40b. Departmenlof the Treasury I AttaCh to Form 990 or Form 990:.Ez' Open To PUbliC Internal Revenue Service lniormation about Schedule (Form 990 or 990-EZ) and its instructions is at inspection Name of the organization PHARMACEUTICAL RESEARCH 8c MANUFACTURERS Employer identification number 01? AMERICA 53?0241211 Part I I Excess Benefit Transactions (section 501(c)(3). section 501(c)(4), and 501(c)(29) organizations only). answered "Yes" on u' 253 Or ri Fari Relationship betWeen disqualified Corrected? Name of disqualified person person and organization Description of transaction 2 Enter the amount of tax incurred by the organization managers or disqualified persons during the year under section 4958 3 Enter the amount of tax, if any, on line 2. above, reimbursed by the organization 33 I Part II I Loans to and/or From Interested Persons. Complete if the organization answered "Yes" on Form 990-EZ. Part V, line 38a or Form 990, Part IV, line 26; or if the organization ne 5 6 or 22. Purpose Loan to or I from the 03.11 ,3 Relationship with organization Name of interested person is) Original principal amount if) Balance due Written agreement? (9) In default? 3" board or To From es No WILLIAM CHIN A 200 000. 200,000izaticn answered on Form ne 7 Name of interested person Relationship between Amount of Type of Purposc of interested person and assistance assistance assistance the organization LHA For Paperwork Reduction Act Notice. see the Instructions for Form 990 or 990-EZ. Schedule (Form 990 or 990-EZ) 2014 SEE PART FOR CONTINUATIONS 432131 10-05?14 1 7 4 12161109 790809 53?0241211 2014.05000 PHARMACEUTICAL RESEARCH 8: 53?02411 PHARMACEUTICAL RESEARCH 8c MANUFACTURERS Schedule (Form 990 or 990422) 2014 OF AMERI Page 2 I Part IV Business Transactions Tnvolving Interested Persons. Complete if the organization answered "Yes" on Form 930. Part IV, line 283, 28b, or 28c. Name of interested person Relationship between interested Amount of Description of sharing 9f . . . . ganlgatron 5 person and the organization transaction transaction reuenue? Yes No METHENY PUBLIC AFFAIRS FORMER KEY EMPLOYEE RICHARD I SMITH KEY EMPLOYEE TIBER CREEK HEALTH KEY EMPLOYEE PartV Supplemental Information Provide additional information for to questions on Schedule (see instructions). SCHEDULE L, PART II, LOANS TO AND FROM INTERESTED PERSONS: (A) NAME OF PERSON: WILLIAM CHIN (C) PURPOSE OF LOAN: DOWNPAYMENT ON HOME IN DC AREA SCH L, PART IV, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS: (A) NAME OF PERSON: METHENY PUBLIC AFFAIRS (B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: FORMER KEY EMPLOYEE WES METHENY IS A PRINCIPAL OF THIS COMPANY (D) DESCRIPTION OF TRANSACTION: CONSULTING SERVICES (A) NAME OF PERSON: RICHARD I SMITH CONSULTING LLC (B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: FORMER KEY EMPLOYEE RICHARD SMITH IS A PRINCIPAL OF THIS COMPANY (D) DESCRIPTION OF TRANSACTION: CONSULTING SERVICES (A) NAME OF PERSON: TIBER CREEK HEALTH STRATEGIES, LLC (B) RELATIONSHIP BETWEEN INTERESTED PERSON AND ORGANIZATION: FORMER KEY EMPLOYEE JAMES BRYANT HALL IS A PRINCIPAL OF THIS COMPANY (D) DESCRIPTION OF TRANSACTION: CONSULTING SERVICES Schedule (Form 990 or 990-EZ) 2014 432132 10?05-14 1'75 12161109 790809 53?0241211 2014.05000 PHARMACEUTICAL RESEARCH 53?02411 . mums?r SCHEDULE 0 Supplemental Information to Form 990 or 990-EZ (Form 990 or 990-Ez) Complete to provide information for responses to specific questions on Form 990 or 990-EZ or to provide any additional information. Department of the Treasury Attach to Form 990 or Open to Inrnuml Revenue Service lntormalion about Schedule 0 {Form 990 nr and its inslructiims is at i'rs Inspection wao?Mogmt?m: PHARMACEUTICAL RESEARCH MANUFACTURERS OF AMERICA 53?0241211 FORM 990, PART I, LINE 1, DESCRIPTION OF ORGANIZATION MISSION: MISSION IS WINNING ADVOCACY FOR PUBLIC POLICIES THAT ENCOURAGE THE DISCOVERY OF LIFE-SAVING AND NEW MEDICINES FOR PATIENTS BY RESEARCH COMPANIES. FORM 990, PART VI, SECTION A, LINE 5: A CORPORATION, SUBSIDIARY OR DIVISION OF A COMPANY WITH OPERATIONS IN THE UNITED STATES THAT IS SIGNIFICANTLY ENGAGED IN THE RESEARCH, MANUFACTURING AND MARKETING OF INNOVATIVE FINISHED DOSAGE PRESCRIPTION PHARMACEUTICAL OR BIOLOGICAL MEDICINES MAY QUALIFY FOR PHRMA MEMBERSHIP. PHRMA HAS TWO CLASSES OF MEMBERSHIP: MEMBERS AND RESEARCH ASSOCIATES. MEMBERS ARE VOTING MEMBERS OF THE ASSOCIATION. RESEARCH ASSOCIATES ARE NON-VOTING MEMBERS. MEMBERS AND RESEARCH ASSOCIATES ARE REPRESENTED ON THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A. LINE 7A: EACH MEMBER OF PHRMA IS ENTITLED TO APPOINT ONE DIRECTOR. SUCH APPOINTMENT IS SUBJECT TO APPROVAL OF THE BOARD OF DIRECTORS FOLLOWING NOMINATION BY THE GOVERNANCE AND COMPENSATION COMMITTEE. FORM 990, PART VI, SECTION A, LINE 7B: CERTAIN MATTERS, SUCH AS AMENDING THE OF THE ASSOCIATION, REQUIRE MEMBER APPROVAL. FORM 990, PART VI, SECTION B, LINE 11: FORM 990 IS PREPARED BY ITS ACCOUNTING FIRM, AND IS REVIEWED LHA For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ. Schedule 0 (Form 990 or 990-EZ) (2014) 432211 08-27-14 176 12161109 790809 53?0241211 2014.05000 PHARMACEUTICAL RESEARCH 53?02411 Schedule 0 (Form 990 or {2014} Page 2 Name of the organization PHARMACEUTICAL RESEARCH 84: MANUFACTURERS Employer identification number OF AMERICA 53-0241211 INTERNALLY BY KEY FINANCIAL MANAGEMENT, THE CFO AND INTERNAL LEGAL COUNSEL. A COPY OF THE FORM 990 IS PROVIDED TO THE BOARD OF DIRECTORS PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C: CONFLICT OF INTEREST POLICY (POLICY) REQUIRES ALL EMPLOYEES TO DISCLOSE ANY FACT OR CIRCUMSTANCE THAT MAY INVOLVE A CONFLICT OF INTEREST TO THE SUPERVISOR OR THE LEGAL DEPARTMENT BEFORE STARTING AN ACTIVITY OR ACQUIRING AN INTEREST WHICH MAY BE QUESTIONABLE. THE POLICY IDENTIFIES SPECIFIC SITUATIONS WHICH MUST BE DISCLOSED BECAUSE A CONFLICT OF INTEREST COULD EXIST. EMPLOYEES ARE DIRECTED TO CONTACT PERSONNEL IN THE LEGAL DEPARTMENT OR FINANCE AND OPERATIONS DEPARTMENT WITH ANY QUESTIONS ABOUT A POSSIBLE CONFLICT OF INTEREST. OFFICERS AND KEY EMPLOYEES MUST COMPLETE AN ANNUAL CERTIFICATION THAT REQUIRES THEM TO CERTIFY THEIR DUTY TO COMPLY WITH THE POLICY AND TO DISCLOSE ANY ACTUAL OR POTENTIAL CONFLICTS OF INTEREST. MEMBERS OF BOARD OF DIRECTORS ARE SUBJECT TO THE CONFLICT OF INTEREST POLICY WITH RESPECT TO MEMBERS OF THE BOARD OF DIRECTORS (DIRECTORS POLICY). THE DIRECTORS POLICY REQUIRES MEMBERS OF THE BOARD OF DIRECTORS TO DISCLOSE THE EXISTENCE OR POSSIBLE EXISTENCE OF ANY CONFLICT OF INTEREST TO THE BOARD OF DIRECTORS AND MEMBERS OF COMMITTEES OF THE BOARD OF DIRECTORS CONSIDERING THE PROPOSED MATTER GIVING RISE, OR RELATING, TO SUCH EXISTING OR POSSIBLE CONFLICT OF INTEREST. THE REMAINING BOARD OF DIRECTORS OR COMMITTEE MEMBERS DETERMINE IF A CONFLICT OF INTEREST EXISTS WITH RESPECT TO THE DIRECTOR WHO MADE THE DISCLOSURE. IF A CONFLICT OF INTEREST IS FOUND TO EXIST, THE INTERESTED DIRECTOR IS BARRED FROM PARTICIPATING IN A MEETING OR ANY RELATED DELIBERATIONS DISCUSSING OR WITH 33371214 Schedule 0 (Form 990 or 990-EZ) (2014) 177 12161109 790809 53?0241211 2014.05000 PHARMACEUTICAL RESEARCH 53?02411 Schedule 0 [Form 9530 or SEED-E2) (BUM) Page 2 Name of the organization PHARMACEUTICAL RESEARCH MANUFACTURERS Employer identification number OF AMERICA 53-0241211 RESPECT TO THE MATTER GIVING RISE TO THE CONFLICT OF INTEREST, RECEIVING ANY COMMUNICATIONS REGARDING SUCH MATTER, AND PARTICIPATING IN OR BEING PRESENT FOR A VOTE ON SUCH MATTER. BOARD MEMBER MUST SIGN AN ANNUAL ACKNOWLEDGEMENT WITH RESPECT TO COMPLIANCE WITH THE DIRECTORS POLICY. FORM 990, PART VI, SECTION B, LINE 15: EACH PERFORMANCE IS ASSESSED ANNUALLY AGAINST SPECIFIC PERFORMANCE OBJECTIVES AND ORGANIZATION VALUES. SENIOR LEADERSHIP, INCLUDING THE REVIEW THESE EVALUATIONS AND MAKE RECOMMENDATIONS FOR ANY COMPENSATION ADJUSTMENTS, INCLUDING MERIT INCREASES AND BONUS APPROPRIATE TO PERFORMANCE AND WITHIN AVAILABLE BUDGET. THESE RECOMMENDATIONS ARE REVIEWED WITH AND APPROVED BY THE GOVERNANCE AND COMPENSATION COMMITTEE OF THE PHRMA BOARD. HUMAN RESOURCES REVIEWS ALL SALARY ADJUSTMENTS TO ASSURE SALARIES REMAIN WITHIN A REASONABLE RANGE COMPARED TO MARKET BENCHMARKS. THE GOVERNANCE COMPENSATION COMMITTEE REVIEWS AND APPROVES MERIT INCREASE, ANNUAL BONUS AND INCENTIVE AWARDS. COMPENSATION IS ESTABLISHED BY BOARD OF DIRECTORS, WITH RECOMMENDATION BY THE GOVERNANCE AND COMPENSATION COMMITTEE. THE GOVERNANCE AND COMPENSATION COMMITTEE CONSIDERS AND APPROVES THE ANNUAL COMPENSATION ADJUSTMENT, ANNUAL BONUS, INCENTIVE AWARD AND DEFERRED COMPENSATION AWARD, BASED ON PERF. TO ANNUAL OBJECTIVES. PHRMA ENGAGES AN INDEPENDENT CONSULTANT TO ADVISE ON EXECUTIVE COMPENSATION, INCLUDING THAT OF THE FORM 990, PART VI, SECTION C, LINE 19: 33.25734 Schedule 0 (Form 990 or 990-52) (2014) 178 12161109 790809 53?0241211 2014.05000 PHARMACEUTICAL RESEARCH 53~02411 Schedule 0 {Form 990 or QQU-EZ) {2014] Page 2 Name of the organization PHARMACEUTICAL RESEARCH 5c MANUFACTURERS Employer identification number OF AMERICA 53-0241211 PHRMA DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY OR FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. FORM 990, PART IX, LINE 11G, OTHER FEES: CONSULTANTS 38,400,037. PRODUCTION, WRITING, EDITING 1,074,239. WEBSITE MAINTENANCE DEV 1,201,224. RECRUITING 888,944. OTHER 317,543. TRANSLATION 252,012. TEMPORARY SERVICES 358,199. TOTAL OTHER FEES ON FORM 990, PART IX, LINE 11G, COL A 42,492,198. FORM 990. PART XI, LINE 9, CHANGES IN NET ASSETS: CHANGES IN PENSION AND POST RETIREMENT ?41,267,570. FORM 990, PART XII, LINE 2C THE AUDIT OVERSIGHT PROCESS REMAINS UNCHANGED FROM THE PRIOR YEAR. 33122271214 Schedule 0 (Form 990 or 990-EZ) (2014) 179 12161109 790809 53?0241211 2014.05000 PHARMACEUTICAL RESEARCH 53?02411 OMS hr; 15 dh?U?d? SCHEDULE Related Organizations and Unrelated Partnerships (Form 990) bComplete if the organization answered "Yes" on Form 990, Part IV. line 33, 34, 35b, 36, or 37. 14 Attach to Form 990. Open to public . Department 0 the Treasury Insp eml?n internal Revenue Sm.? )lnforrnation about Schedule Form 996 and its instructions is at Name of the organization PHARMACEUTICAL RESEARCH 8: MANUFACTURERS Employer identification number OF AMERICA Partl Identi?cation of Disregarded Entities Complete if the organization answered "Yes" on Form 990, Part IV, line 33. (bi (C) if} Name. address, and EIN ?f applicable) Primary activity Legal domicile (state or Total income End-of?year assets Direct controlling of disregarded entity foreign country) entity Identification of Related Tax-Exempt Organizations Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related tax-exempt organizations during the tax year. Section(g1)2(b)(13) Name, address. and EIN Primary activity Legal domicile (state or Exempt Code Public charity Direct controlling controlled of related organization foreign country) section status (if section entity entity? Part II 501(c)(3)) Yes No PHRMA PAC 20?4447742 1127 11TH STREET SUITE 300 CA 95814 POLITICAL CALIFORNIA 527 PHRMA INDEPENDENT EXPENDITURE COMMITTEE 90?02396521 1127 11TH STREET SUITE 300. CA 95814 POLITICAL CALIFORNIA 527 PHRMA COLORADO ACTION FUND 20?5123531 1740 BROADWAY DENVER, co 80274 POLITICAL COLORADO 527 EC PHRMA BETTER GOVERNMENT COMMITTEE 52?1606127, 950 WASHINGTON, Dc 20004 POLITICAL DISTRICT OF COLUMBIA 527 Ii For Paperwork Reduction Act Notice. see the Instructions for Form 990. Schedule (Form 990) 2014 432161 03?14-14 LHA 18 0 PHARMACEUTI CAL RESEARCH MANUFACTURERS Schedule [Form 990) OF AMERICA Continuation of Identification of Related Tax-Exempt Organizations Section(g1)2(b)(13] Name, address, and Primary activity Legal domicile (state or Exempt Code Public charity Direct controlling controlled of related organization foreign country) section status (if section entity organization? 501(c)(3)) Yes No PHRMA TN PAC 53?0241211 950 STREET, NW DC 20004 POLITICAL TENNESSEE 527 432222 05?0 1? 14 181 PHARMACEUTI CAL RESEARCH Sc MANUFACTURERS Schedule (Form 990) 2014 OF AMERICA Pane 2 Part Identification of Related Organizations Taxable as a Partnership Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related organizations treated as a partnership during the tax yearName, address, and Primary activity (1:295:18 Direct controlling Predominant income Share of total Share of Disproportlonate Code V-UBI Gama! Percentage of related organization (state or entity ?related, unrelated, income end-of?year allocations? amount in box moi!me foreign exc uded from tax under assets 20 of schedule parln? country) sections 512-514) yes No K-?l (Form 1065) Yes No Part Iv Identification of Related Organizations Taxable as a Corporation or Trust Complete if the organization answered "Yes" on Form 990, Part IV. line 34 because it had one or more related organizations treated as a corporation or trust during the tax year. if) Segre? Name, address, and Primary activity Legal domicile Direct controlling Type of entity Share of total Share of Percentage 512(b)(13) 0f re'atE?d Organization (state or entity (C corp, corp, Income end-of?year ownership Emilio"? or trust) assets 9" ?w country) Yes No 432162 08-14-14 Schedule Fl (Form 990) 2014 1 8 2 Schedule (Form 990) 2014 Part PHARMACEUTICAL RESEARCH MANUFACTURERS OF AMERICA Transactions With Related Organizations Complete if the organization answered "Yes" on Form 990, Part IV, line 34. 35b, or 36. Page3 Note. Complete line 1 if any entity is listed in Parts II, or of this schedule. 1 During the tax year, did the organization engage in any of the following transactions with one or more related organizations listed in Parts il-IV? hm; Receipt of interest, (ii) annuities, royalties, or (iv) rent from a controlled entity Gift, grant, or capital contribution to related organization(s) Gift, grant, or capital contribution from related organization(s) Loans or loan guarantees to or for related organization(s) Loans or loan guarantees by related organization(s) Dividends from related organization(s) Sale of assets to related org anization(s) Purchase of assets from related organization(s) i Exchange of assets with related organization(s) Eco O. Lease of facilities, equipment, or other assets to related organization(s) Lease of facilities, equipment, or other assets from related organization(s) Performance of services or membership or fundraising solicitations for related organization(s) Performance of services or membership or fundraising solicitations by related organization(s) Sharing of facilities, equipment, mailing lists, or other assets with related organization(s) Sharing of paid employees with related organization(s) Reimbursement paid to related organization(s) for expenses Reimbursement paid by related organization(s) for expenses Other transfer of cash or property to related organization(s) 5 Other transier of cash or property from related organization(the answer to any of the above is "Yes," see the instructions tor information who must complete this line, including covered relationships and transaction thresholds. (m Name of related organization in Transaction bmees (d Amount involved to Method of determining amount involved PHRMA PAC 96,000 CASH XFER AS COLLECTION AGENT PHRMA INDEPENDENT EXPENDITURE COMMITTEE 507,998 CASH XFER AS COLLECTION AGENT is} PHRMA BETTER GOVT 132,153 CASH XFER AS COLLECTION AGENT (51 PHRMA TN PAC 10,000 CASH XFER AS COLLECTION AGENT CO PAC 100.000 CASH XFER AS COLLECTION AGENT PAC 20,000 PAC CONTRIBUTION 432163 03-14?14 Schedule (Form 990) 2014 PHARMACEUTI CAL RESEARCH Sc MANUFACTURERS Schedule {Form 990} 2014 OF AMERICA 53*0241211 Pager: Part VI Unrelated Organizations Taxable as a Partnership Complete if the organization answered "Yes" on Form 990. Part IV. line 37. Provide the following information for each entity taxed as a partnership through which the organization conducted more than five percent of its activities (measured by total assets or gross revenue) that was not a related organization. See instructions regarding exclusion for certain investment partnerships. (bi Alee)Ir lf) (9) (M ii) a Share of Share of Dispmunr- Cocle V-UBI Gonml Percentage Name, address. and EIN Primary activity Legal domicile Predominant income ua?tnersse: ?ow I . rm uraa mg . of entity (Irelatedr unrelated, ll?) total end.0f.year allocamns? OWnership (State or fore'gn exc uded from tax under nrcs. . Income assets Yes No (Form 1065) Yes No country) sections 512-514) ves No Schedule (Form 990) 2014 432164 05?14-14 184 PHARMACEUTICAL RESEARCH MANUFACTURERS OF AMERICA 53?0241211 Pmes Part I Supplemental Information Provide additional information for responses to questions on Schedule (see instructions). 432165 03-14-14 Schedule (Form 990) 2014 185 12161109 790809 53?0241211 2014.05000 PHARMACEUTICAL RESEARCH 53?02411 Form 8868 Application for Extension of Time To File an (Rev. January 2014) Exempt Organization Return OMB No. 15454709 Department? the Treasury ?le a separate application for each return. Internal Reyenue Service Information about Form 8868 and its instructions is at gov/form8868 . 0 If you are filing for an Automatic 3-Month Extension, complete only Partl and check this box IE 0 If you are filing for an Additional (Not Automatic) 3-Month Extension. complete only Part II (on page 2 of this form). Do not complete Pant 1/ unless you have already been granted an automatic 13-month extension on a previously filed Form 8868. Electronic ?ling {ewe/1 You can electronically file Form 8858 if you need a Smooth automatic extension of time to file (0 months fOr a corporation required to file Form 990T), or an additional (not automatic) 3-month extension of time. You can electronically file Form 8868 to request an extension of time to file any of the forms listed in Part or Part II with the exception of Form 8870, Information Return for Transfers Associated With Certain Personal Benefit Contracts, which must be sent to the IRS in paper format (see instructions). For more details on the electronic filing of this form, ViSit irs oovrefile arid Gli?k Oh e-frtetor Charities Noimrofits. Part I I Automatic 3-Month Extension of Time. Only submit original (no cepies needed}. A corporation required to file Form 990-T and requesting an automatic 6-month extension - check this box and complete Part only El All other corporations (including 1120?0 ?lers), partnerships, REMICs, and trusts must use Form 7004 to request an extension of time to file income tax returns Enter ?rafts iden?wgnq number Type or Name of exempt organization or other filer, see instructions. Employer identification number or print PHARMACEUTICAL RESEARCH Sc MANUFACTURERS Filebythe OF AMERICA 53?0241211 due dateror Number, street, and room or suite no. If a PO. box, see instructions. Social security number (SSN) my); 9 5 0 STREET NO. 3 0 0 instructions City, town or post office, state, and ZIP code. For a foreign address, see instructions. WASHINGTON DC 2 0 0 0 4 Enter the Return code for the return that this application is for (file a separate application for each return) a Application is Form 990 or Form BSD-E2 Return Application Return Form BSD-T Form 1041 -A 4720 01 Form 4720 990-PF er than indi Form BSD-T 70 PAUL A. AINES (INCOMING CFO) 0 Thebooksareinthecareof> 950 STREET, NO. 300 - WASHINGTON, DC 20004 ll TelephoneNo)? 202?835-3400 FaxNo. 0 If the organization does not have an office or place of business in the United States, check this box 0 If this is for a Group Return, enter the organization?s four digit Group Exemption Number (GEN) . If this is for the whole group, check this box I: . If it is for part of the qroup, check this box [j and attach a list with the names and Ele of all members the extension is for. 1 I request an automatic 3-month (6 months for a corporation required to file Form 990T) extension of time until AUGUST 1 5 2 0 5 to file the exempt organization return for the organization named above. The extension is for the organization?s return for: calendar year 2 0 1 4 or tax year beginning and ending 2 If the tax year entered in line 1 is for less than 12 months, check reason: Initial return Final return [j Change in accounting period 3a If this application is for Forms QQO-BL, 990-PF, 990-T, 4720, or 6069, enter the tentative tax, less any nonrefundable credits. See instructions. 3a 5 0 . If this application is for Forms 990-PF, 990-T, 4720, or 6069, enter any refundable credits and estimated tax payments made. Include any prior year overpayment allowed as a credit. 3b 6 0 . Balance due. Subtract line 3b from line 3a. Include your payment with this form, if required, by Using {Electronic Federal Tax Payment System}. See instructions. 3c 5 0 . Caution. If you are going to make an electronic funds withdrawal (direct debit) with this Form 8868, see Form 8453-EO and Form 8879-EO for payment instructions. Iii-sigh? For Privacy Act and Paperwork Reduction Act Notice, see instructions. Form 8868 (Rev. 1-2014) 05-01-14 1 12161109 790809 53-0241211 2014.05000 PHARMACEUTICAL RESEARCH 8.: 53?02411 Form 8868 (Rev. 120144) Page 2 0 If you are filing for an Additional (Not Automatic) 3-Month Extension, complete only Part II and check this box Note. Only complete Part if you have already been granted an automatic 3-month extension on a previously filed Form 8868. 0 If you are filing for an Automatic 3-Month Extension, complete only Part I [on page [Part ll] Additional (Not Automatic) B?Month Extension of Time. Only file the original {no copies needed}. Enter filer's identifying number, see instructions Type or Name of exempt organization or other filer, see instructions. Employer identification number (EIN) or print PHARMACEUTICAL RESEARCH MANUFACTURERS Filebythe OF AMERICA 53-0241211 2::gd?jfm Number, street. and room or suite no. If a PO. box, see instructions. Social security number (SSN) return See 9 5 0 STREET NO . 3 0 0 instm?ons City, town or post office, state, and ZIP code. For a foreign address, see instructions. WASHINGTON DC 2 0 0 4 Enter the Return code for the return that this application is for (file a separate application for each return) Application Form 980 or Form Form Return Application Return Code 01 Form 1041-A Form 4720 7 03 04 05 ther than individ Form sail-PF Form 6069 70 Do not complete Part II it you were not alrea?y ?nted an automatic 3-month extension on a previoust fiied Form 8853. PAUL A . AINES INCOMING CFO) 0 The books are in the care of 9 5 0 STREET NO . 3 0 0 - WASHINGTON DC 2 0 0 0 4 TelephoneN0.> 202?835?3400 FaxNo. 0 If the organization does not have an office or place of business in the United States, check this box If this is for a Group Return, enter the organization's four digit Group Exemption Number (GEN) . If this is for the whole group, check this box i:l . If it is for_part of the group. check this box I and attach a list with the names and EINs of all members the extension is for. 4 request an additional 3-month extension of time until NOVEMBER For calendar year 2 0 4 or other tax year beginning and ending 6 If the tax year entered in line 5 is for less than 12 months, check reason: Initial return Final return Change in accounting period 7 State in detail why you need the extension THE INFORMATION NECESSARY TO FILE A COMPLETE AND ACCURATE RETURN HAS NOT YET BEEN OBTAINED. 8a If this application is for Forms 990-BL, 990-PF, 990T, 4720, or 6069, enter the tentative tax, less any nonrefundable credits. See Instructions. 83 5 0 . If this application is for Forms 990-PF, 990-T, 4720, or 6069, enter any refundable credits and estimated tax payments made. Include any prior year overpayment allowed as a credit and any amount paid previously with Form 8868. at; 0 . '3 Balance due. Subtract line 8b from line 8a. Include your payment with this form, if required, by using EFIPS {Electronic Federal Tax Payment System}. See instructions. 8c 13 0 . Signature and Verification must be completed for Part It only. Under penalties of perjury, I declare that I have examined this form, including accompanying schedules and statements, and t0 the best of my knowledge and belief, it is true, correctgand complete, and that I am authorized to prepare this form. Signature .J. L?J??i?j-ih ?Title CPA Date 08/04/15 Form 8868 (Rev. 12014) 423342 09?15-14 186 12161109 790809 53e0241211 2014.05000 PHARMACEUTICAL RESEARCH 53?02411